MCID: DRM006
MIFTS: 62

Dermatitis

Categories: Skin diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Dermatitis

MalaCards integrated aliases for Dermatitis:

Name: Dermatitis 11 53 5 43 14 71 75
Eczema 11 75 28 53 5 41 63 71
Skin Inflammation 11 14
Inflammatory Dermatosis 71

Classifications:



External Ids:

Disease Ontology 11 DOID:2723
MeSH 43 D003872
NCIt 49 C2983
SNOMED-CT 68 238538009
UMLS 71 C0011603 C0013595 C3875321

Summaries for Dermatitis

MedlinePlus: 41 Eczema is a term for several different types of skin swelling. Eczema is also called dermatitis. Most types cause dry, itchy skin and rashes on the face, inside the elbows and behind the knees, and on the hands and feet. Scratching the skin can cause it to turn red, and to swell and itch even more. Eczema is not contagious. The cause of eczema is unknown. It is likely caused by both genetic and environmental factors. Eczema may get better or worse over time, but it is often a long-lasting disease. People who have it may also develop hay fever and asthma. The most common type of eczema is atopic dermatitis. It is most common in babies and children, but adults can have it too. As children who have atopic dermatitis grow older, this problem may get better or go away. But sometimes the skin may stay dry and get irritated easily. Treatments may include medicines, skin creams, light therapy, and good skin care. You can prevent some types of eczema by avoiding: Things that irritate your skin, such as certain soaps, fabrics, and lotions Stress Things you are allergic to, such as food, pollen, and animals NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

MalaCards based summary: Dermatitis, also known as eczema, is related to irritant dermatitis and dermatitis herpetiformis, and has symptoms including pruritus and exanthema. An important gene associated with Dermatitis is FLG (Filaggrin), and among its related pathways/superpathways are Innate Immune System and MIF Mediated Glucocorticoid Regulation. The drugs Salicylic acid and Ciclopirox have been mentioned in the context of this disorder. Affiliated tissues include skin, breast and t cells, and related phenotypes are immune system and hematopoietic system

PubMed Health : 63 Eczema: Eczema is a common, chronic, non-infectious skin condition. The main symptom of this inflammatory disease is a very itchy rash. It often affects children. In many cases eczema gets better as the years go by, and it may go away for a while or disappear altogether. Acute flare-ups can really affect quality of life. The itching can be especially bad, making it difficult to concentrate and sleep well. Some people are embarrassed if their rash is visible to others. By taking good care of your skin, using medication and avoiding irritants and other things that can trigger the eczema, it is usually possible to relieve the symptoms at least enough to live a fairly normal life. Eczema is sometimes also called "atopic eczema" or "atopic dermatitis."

Disease Ontology: 11 A skin disease characterized by itchy, erythematous, vesicular, weeping and crusting patches of skin.

Wikipedia: 75 Dermatitis is inflammation of the skin, typically characterized by itchiness, redness and a rash. In... more...

Related Diseases for Dermatitis

Diseases related to Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 2086, show less)
# Related Disease Score Top Affiliating Genes
1 irritant dermatitis 33.2 TSLP IL4 IL31 IL13 FLG CCL27
2 dermatitis herpetiformis 33.2 IL5 IL4 IL31 CCL11
3 allergic contact dermatitis 33.2 TSLP SPINK5 IL5 IL4 IL31RA IL31
4 contact dermatitis 33.2 TSLP SPINK5 IL5 IL4 IL31RA IL31
5 dermatitis, atopic 33.2 TSLP SPINK5 NOD2 IL5 IL4 IL31RA
6 seborrheic infantile dermatitis 33.0 ZNF750 FLG
7 cercarial dermatitis 33.0 IL5 IL4
8 eczema herpeticum 32.9 TSLP SPINK5 IL4 IL31 IL13 IGHE
9 occupational dermatitis 32.8 IL31 FLG
10 seborrheic dermatitis 32.7 ZNF750 SPINK5 FLG DSG1 BTD
11 nickel allergic contact dermatitis 32.7 IL5 IL13
12 chromium allergic contact dermatitis 32.6 IL5 IL4 IL13
13 blau syndrome 32.6 NOD2 NLRP3 IL4
14 allergic rhinitis 32.4 IL5 IL4 IL13 IGHE CCL17 CCL11
15 bullous pemphigoid 32.3 IL5 IL4 IGHE DSG1 CCL17 CCL11
16 celiac disease 1 32.3 TSLP NOD2 IL5 IL4 IL13
17 netherton syndrome 32.3 SPINK5 IGHE FLG DSG1
18 allergic asthma 32.2 TSLP IL5 IL4 IL13 IGHE CCL17
19 ige responsiveness, atopic 32.2 SPINK5 IL5 IL4 IL13 IGHE
20 chronic rhinitis 32.1 IL5 IL4 IL13
21 metal allergy 32.1 IL5 IL4 IL13 FLG
22 milk allergy 32.1 TSLP IL5 IL4 IL13 IGHE
23 egg allergy 32.0 TSLP IL5 IL4 IL13 IGHE FLG
24 hyper ige syndrome 32.0 SPINK5 IL4 IGHE CCL11
25 rhinitis 32.0 TSLP IL5 IL4 IL13 IGHE FLG
26 food allergy 32.0 TSLP IL5 IL4 IL13 IGHE FLG
27 neurodermatitis 32.0 TSLP IL4 IL31RA IL31 IL13 FLG
28 pollen allergy 32.0 IL5 IL4 IL13
29 skin disease 32.0 TSLP SPINK5 NOD2 NLRP3 IL5 IL4
30 allergic disease 32.0 TSLP IL5 IL4 IL13 IGHE FLG
31 filariasis 31.9 IL5 IL4 IL13 IGHE
32 onchocerciasis 31.9 IL5 IL4 IL13 IGHE DSG1 CCL11
33 psoriasis 31.9 SPINK5 NOD2 IL5 IL4 IL31 IL13
34 pyoderma 31.9 NOD2 NLRP3 DSG1
35 asthma 31.8 TSLP SPINK5 NOD2 NLRP3 IL5 IL4
36 urticaria 31.7 TSLP NLRP3 IL5 IL4 IL31 IL13
37 hypereosinophilic syndrome 31.7 IL5 IL4 IL13 IGHE CCL17 CCL11
38 conjunctivitis 31.7 NLRP3 IL5 IL4 IL13 IGHE CCL11
39 erythema multiforme 31.6 IL5 IL4 IL13 CCL17
40 pemphigoid 31.5 IL5 IL4 IL31 IL13 DSG1 CCL11
41 fungal infectious disease 31.5 IL5 IL4 IL13
42 folliculitis 31.5 IL5 IL4 CCL11
43 skin atrophy 31.4 IL4 IL31 FLG
44 mycosis fungoides 31.4 IL5 IL4 CCL22 CCL17
45 lichen planus 31.4 IL4 FLG DSG1
46 ichthyosis vulgaris 31.4 TSLP SPINK5 FLG DSG1
47 alopecia areata 31.4 IL4 IL13 FLG
48 scabies 31.3 IL5 IL4 IL31 IL13 FLG
49 schistosomiasis 31.3 IL5 IL4 IL13 IGHE
50 primary cutaneous t-cell non-hodgkin lymphoma 31.3 IL5 IL4 CCL17
51 allergic conjunctivitis 31.3 TSLP IL5 IL4 IL13 IGHE CCL11
52 chronic urticaria 31.3 NLRP3 IL5 IL31 IGHE
53 proteasome-associated autoinflammatory syndrome 1 31.2 NLRP3 IL5 IL4 IL13 IGHE CCL11
54 respiratory allergy 31.2 TSLP IL5 IL4 IL13 FLG CCL17
55 keratoconjunctivitis 31.2 IL5 IL4 IL13 CCL11
56 nasopharyngitis 31.2 IL5 IL31 IL13
57 common cold 31.2 TSLP IL5 IL4 IL13 CCL11
58 chronic spontaneous urticaria 31.1 TSLP IL5 IL4 IL31 IL13
59 bronchitis 31.0 IL5 IL4 IL13 IGHE CCL11
60 leishmaniasis 31.0 IL5 IL4 IL13
61 eosinophilic gastroenteritis 31.0 IL5 IL4 IL13 IGHE CCL11
62 peanut allergy 31.0 TSLP IL5 IL4 IL13 IGHE FLG
63 sezary's disease 31.0 IL5 IL4 IL31 CCL27 CCL17
64 respiratory failure 30.9 NLRP3 IL5 IL4 IL13 IGHE CMA1
65 occupational asthma 30.9 TSLP IL5 IL4 IL13 CCL11
66 ulcerative colitis 30.9 NOD2 IL5 IL4 IL13
67 mite infestation 30.9 TSLP IL5 IL4 IL31 IL13 FLG
68 drug allergy 30.9 IL5 IL4 IL13 IGHE
69 leprosy 3 30.9 NOD2 IL5 IL4 IL13
70 esophagitis 30.9 TSLP IL5 IL4 IL13 FLG DSG1
71 childhood-onset asthma 30.9 TSLP IL5 IL4 IL13 IGHE CCL17
72 candidiasis 30.9 NLRP3 IL5 IL4
73 aspergillosis 30.9 NOD2 IL5 IL4 CCL17
74 ascaris lumbricoides infection 30.8 IL5 IL4 IL13
75 blepharoconjunctivitis 30.8 IL4 IL13
76 colitis 30.8 NOD2 IL5 IL4 IL13
77 crohn's disease 30.8 NOD2 NLRP3 IL5 IL4 IL13
78 diphtheria 30.8 IL5 IL4 IL13
79 esophagitis, eosinophilic, 1 30.8 TSLP SPINK5 IL5 IL4 IL13 FLG
80 hidradenitis 30.8 NOD2 NLRP3 DSG1
81 tetanus 30.7 IL5 IL4 IL13
82 osteomyelitis 30.7 NOD2 NLRP3 IL4
83 severe combined immunodeficiency 30.7 IL5 IL4 IL13 IGHE
84 parasitic helminthiasis infectious disease 30.7 TSLP IL5 IL4 IL13 CCL11
85 gastroenteritis 30.7 IL5 IL4 CCL11
86 otitis media 30.6 SPINK5 NLRP3 IL5 IL4 IL13 IGHE
87 cow milk allergy 30.6 IL5 IL4 IL13
88 latex allergy 30.6 IL13 IGHE
89 uveitis 30.6 NOD2 IL4 CCL11
90 churg-strauss syndrome 30.6 IL5 CCL17 CCL11
91 filarial elephantiasis 30.5 IL5 IL4 IL13
92 cutaneous leishmaniasis 30.5 IL5 IL4 IL13 IGHE
93 toxoplasmosis 30.5 NOD2 IL5 IL4
94 strongyloidiasis 30.5 IL5 IL4 IL13 IGHE CCL11
95 bronchiolitis 30.5 IL5 IL4 IL13 CCL11
96 cystic fibrosis 30.5 NOD2 NLRP3 IL5 IL4 IL13 CCL17
97 intrinsic asthma 30.5 TSLP IL5 IL4 IL13 IGHE CCL11
98 vernal keratoconjunctivitis 30.5 IL4 IL13 CCL11
99 meningitis 30.5 NLRP3 IL5 IL4 IL13
100 interstitial lung disease 30.5 IL4 IL13 CCL17 CCL11
101 vasomotor rhinitis 30.5 IL5 IL4 IL13 CMA1 CCL11
102 omenn syndrome 30.4 SPINK5 IL5 IL4 IGHE
103 enterobiasis 30.4 IL5 IL4
104 behcet syndrome 30.4 NOD2 NLRP3 IL5 IL4 IL13
105 norwegian scabies 30.4 IL5 IL13 CCL27
106 exercise-induced bronchoconstriction 30.4 TSLP IL5 IL4 IL13 IGHE
107 pneumonia 30.4 IL5 IL4 IL13 CCL22 CCL11
108 acute asthma 30.3 TSLP IL5 IL4 IL13 CCL11
109 peeling skin syndrome 30.3 SPINK5 FLG DSG1
110 kimura disease 30.3 IL5 IL4 IGHE
111 elephantiasis 30.3 IL5 IL4 IL13
112 respiratory syncytial virus infectious disease 30.2 IL5 IL13
113 peritonitis 30.2 NOD2 NLRP3 CMA1
114 conjunctival disease 30.2 TSLP NLRP3 IL5 IL4 IL13 CCL11
115 chronic asthma 30.2 TSLP IL5 IL4 IL13 CCL17 CCL11
116 chronic conjunctivitis 30.1 TSLP IL5 IL4 IL13 IGHE CMA1
117 toxocariasis 30.0 IL5 IL4 IL13 IGHE
118 mucocutaneous leishmaniasis 30.0 IL5 IL4 IL13
119 loiasis 30.0 IL5 IL4 IL13 CCL11
120 igg4-related disease 30.0 IL5 IL4 IL13
121 intestinal schistosomiasis 30.0 IL5 IL4 IL13
122 t2-high asthma 30.0 TSLP IL5 IL4 IL13
123 mansonelliasis 30.0 CCL22 CCL17
124 parasitic ectoparasitic infectious disease 30.0 IL5 IL4 IL31 IL13 FLG
125 allergic bronchopulmonary aspergillosis 30.0 IL5 IL4 IL13 IGHE CCL17
126 radiculopathy 30.0 IL5 IL13 CCL11
127 interstitial lung disease 2 30.0 TSLP NLRP3 IL5 IL4 IL13 CCL22
128 eosinophilic pneumonia 30.0 IL5 IL4 IL13 CCL22 CCL17 CCL11
129 vernal conjunctivitis 30.0 IL4 CMA1 CCL11
130 visceral leishmaniasis 29.9 IL5 IL4 IL13
131 disseminated eosinophilic collagen disease 29.9 IL5 CCL17
132 esophageal candidiasis 29.9 IL5 IL13
133 brucellosis 29.8 NLRP3 IL4 IL13
134 familial mediterranean fever 29.8 NOD2 NLRP3 IL4
135 silicosis 29.8 NLRP3 IL4 DSG1
136 dacryoadenitis 29.5 IL4 IL13
137 dermatitis, atopic, 2 11.6
138 chronic actinic dermatitis 11.5
139 immunodeficiency 11b with atopic dermatitis 11.5
140 toxicodendron dermatitis 11.4
141 microcephaly, congenital cataract, and psoriasiform dermatitis 11.4
142 photoallergic dermatitis 11.4
143 dermatitis, atopic, 3 11.4
144 phototoxic dermatitis 11.4
145 erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige 11.4
146 dermatitis, atopic, 5 11.4
147 dermatitis, atopic, 4 11.4
148 exfoliative dermatitis 11.4
149 dermatitis, atopic, 6 11.4
150 dermatitis, atopic, 8 11.4
151 dermatitis, atopic, 7 11.4
152 seborrhea-like dermatitis with psoriasiform elements 11.4
153 interstitial granulomatous dermatitis with arthritis 11.4
154 dermatitis, atopic, 9 11.4
155 agammaglobulinemia, microcephaly, and severe dermatitis 11.3
156 infective dermatitis associated with htlv-1 11.3
157 1,4-phenylenediamine allergic contact dermatitis 11.3
158 1-chloro-2,4-dinitrobenzene allergic contact dermatitis 11.3
159 granulomatous dermatitis 11.3
160 benzo[d]isothiazol-3-one allergic contact dermatitis 11.2
161 autoinflammation, immune dysregulation, and eosinophilia 11.2
162 palladium allergic contact dermatitis 11.2
163 4-tert-butylphenol allergic contact dermatitis 11.2
164 neurotic excoriation 11.2
165 spongiotic dermatitis 11.2
166 contagious pustular dermatitis 11.2
167 cobalt allergic contact dermatitis 11.2
168 diphenylmethane-4,4'-diisocyanate allergic contact dermatitis 11.2
169 benzoic acid allergic contact dermatitis 11.2
170 ketoprofen photoallergic dermatitis 11.2
171 carvone allergic contact dermatitis 11.2
172 neomycin sulfate allergic contact dermatitis 11.2
173 parthenolide allergic contact dermatitis 11.2
174 formaldehyde allergic contact dermatitis 11.2
175 2,4-dinitrophenyl allergic contact dermatitis 11.2
176 juvenile dermatitis herpetiformis 11.2
177 acrodermatitis enteropathica, zinc-deficiency type 11.2
178 growth retardation, small and puffy hands and feet, and eczema 11.2
179 acneiform dermatitis 11.1
180 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 11.1
181 progestogen hypersensitivity 11.1
182 potassium dichromate allergic contact dermatitis 11.1
183 n,n'-diphenylthiourea allergic contact dermatitis 11.1
184 n,n'-diethylthiourea allergic contact dermatitis 11.1
185 dermatophytosis 11.1
186 holocarboxylase synthetase deficiency 11.1
187 subcorneal pustular dermatosis 11.1
188 thrombocytopenia 1 11.1
189 noonan syndrome-like disorder with loose anagen hair 11.1
190 photoparoxysmal response 1 11.0
191 dermatitis herpetiformis, familial 11.0
192 autoimmune disease, multisystem, infantile-onset, 1 11.0
193 immunodeficiency 63 with lymphoproliferation and autoimmunity 11.0
194 acrodermatitis 11.0
195 autoinflammatory syndrome, familial, x-linked, behcet-like 2 11.0
196 allergic contact dermatitis of eyelid 11.0
197 garret tripp syndrome 11.0
198 pellagra 11.0
199 wiskott-aldrich syndrome 2 11.0
200 myeloproliferative/lymphoproliferative neoplasms, familial 11.0
201 growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant 11.0
202 autoinflammatory syndrome, familial, with or without immunodeficiency 11.0
203 immunodeficiency 85 and autoimmunity 11.0
204 asthma-related traits 4 11.0
205 psoriasis 2 10.9
206 psoriasis 11 10.9
207 psoriasis 1 10.9
208 psoriasis 7 10.9
209 psoriasis 13 10.9
210 porphyria cutanea tarda 10.9
211 asthma-related traits 2 10.9
212 immunodeficiency 23 10.9
213 yao syndrome 10.9
214 immunodeficiency 58 10.9
215 prurigo nodularis 10.9
216 systemic lupus erythematosus 10.9
217 ameloonychohypohidrotic syndrome 10.9
218 asthma-related traits 1 10.9
219 zinc deficiency, transient neonatal 10.9
220 asthma-related traits 5 10.9
221 asthma-related traits 7 10.9
222 proteasome-associated autoinflammatory syndrome 3 10.9
223 proteasome-associated autoinflammatory syndrome 2 10.9
224 hyper-ige recurrent infection syndrome 3, autosomal recessive 10.9
225 t-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant 10.9
226 hyper-ige recurrent infection syndrome 5, autosomal recessive 10.9
227 stuve-wiedemann syndrome 2 10.9
228 ritter's disease 10.9
229 chromoblastomycosis 10.9
230 leiner disease 10.9
231 tropical spastic paraparesis 10.9
232 exanthem 10.9
233 agammaglobulinemia, x-linked 10.9
234 fixed drug eruption 10.9
235 pigmented purpuric eruption 10.9
236 deafness, neural, with atypical atopic dermatitis 10.9
237 atopic keratoconjunctivitis 10.8
238 pityriasis rosea 10.8
239 biotinidase deficiency 10.8
240 drug reaction with eosinophilia and systemic symptoms 10.8
241 eczematous dermatitis of eyelid 10.8
242 growth hormone insensitivity syndrome with immune dysregulation 1, autosomal recessive 10.8
243 hyperphenylalaninemia, bh4-deficient, a 10.8
244 immunodeficiency 50 10.8
245 chromosome 2q37 deletion syndrome 10.8
246 nicolaides-baraitser syndrome 10.8
247 chromosome 15q11-q13 duplication syndrome 10.8
248 immunodeficiency 31c 10.8
249 loeys-dietz syndrome 4 10.8
250 immunodeficiency 7 10.8
251 loeys-dietz syndrome 5 10.8
252 immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia 10.8
253 immunodeficiency 55 10.8
254 trueb burg bottani syndrome 10.8
255 hereditary thrombocytopenia with normal platelets 10.8
256 intellectual disability-seizures-macrocephaly-obesity syndrome 10.8
257 congenital progressive bone marrow failure-b-cell immunodeficiency-skeletal dysplasia syndrome 10.8
258 actinic prurigo 10.8
259 primary cutaneous amyloidosis 10.8
260 ackerman syndrome 10.8
261 balanitis 10.8
262 fish allergy 10.8
263 balanoposthitis 10.8
264 bullous skin disease 10.8
265 erosive pustular dermatosis of the scalp 10.8
266 macular amyloidosis 10.8
267 13q12.3 microdeletion syndrome 10.8
268 deep dermatophytosis 10.8
269 kindler syndrome 10.8
270 nail disorder, nonsyndromic congenital, 4 10.8
271 vexas syndrome 10.8
272 neurodevelopmental disorder with epilepsy and hemochromatosis 10.8
273 mental retardation, obesity, mandibular prognathism, and eye and skin anomalies 10.8
274 immunodeficiency 104 10.8
275 asthma-related traits 3 10.8
276 asthma-related traits 6 10.8
277 immunodeficiency, common variable, 8, with autoimmunity 10.8
278 immunodeficiency 12 10.8
279 autoinflammation, panniculitis, and dermatosis syndrome 10.8
280 immunodeficiency 82 with systemic inflammation 10.8
281 immunodeficiency 105 10.8
282 large congenital melanocytic nevus 10.8
283 mercury poisoning 10.8
284 linear atrophoderma of moulin 10.8
285 alopecia 10.7
286 rosacea 10.6
287 acne 10.6
288 pemphigus 10.6
289 cytokine deficiency 10.6
290 autoimmune disease 10.6
291 ichthyosis 10.5
292 thunderstorm triggered asthma 10.5 IL5 IL4 IL13
293 cough variant asthma 10.5 IL5 IL4 IL13
294 mikulicz disease 10.5 IL5 IL4 IL13
295 penicillin allergy 10.5 IL4 IL13 IGHE
296 nut allergy 10.5 IL5 IL4 IL13 IGHE FLG
297 urinary schistosomiasis 10.5 IL5 IL4 IL13 IGHE
298 angiostrongyliasis 10.5 IL5 IL13 CCL11
299 papillary conjunctivitis 10.5 IL5 IL4 IL13 CCL11
300 persistent severe asthma 10.5 TSLP IL5 IL4 IL13
301 aztreonam allergy 10.5 IL5 IL13
302 paragonimiasis 10.5 IL5 IL13 IGHE CCL17
303 eosinophilic meningitis 10.5 IL5 IL4 IL13 CCL11
304 taeniasis 10.5 IL5 IL4 IL13
305 cysticercosis 10.5 IL5 IL4 IGHE
306 near-fatal asthma 10.5 TSLP IL5 IL4 IL13
307 t2-low asthma 10.5 TSLP IL5 IL4 IL13
308 contact blepharoconjunctivitis 10.5 IL5 CCL11
309 giant papillary conjunctivitis 10.5 IL5 IL4 IL13 CCL11
310 rickets 10.5
311 chronic eosinophilic pneumonia 10.5 IL5 IL13 CCL11
312 viral infectious disease 10.5
313 eosinophilic gastritis 10.5 TSLP IL5 IL13 CCL11
314 cefaclor allergy 10.5 IL5 IL13
315 status asthmaticus 10.5 IL5 IL13 CCL11
316 adult syndrome 10.5
317 trichinosis 10.5 TSLP IL5 IL4 IL13 CCL11
318 intermittent asthma 10.5 TSLP IL5 IL4 IL13 CCL11
319 vitiligo-associated multiple autoimmune disease susceptibility 6 10.5
320 vitiligo-associated multiple autoimmune disease susceptibility 1 10.5
321 environmental induced asthma 10.5 TSLP IL5 IL4 IL13 CCL11
322 pulmonary eosinophilia 10.5 IL5 IL4 IL13 CCL17 CCL11
323 opportunistic mycosis 10.5 IL5 IL4 IL13
324 paranasal sinus disease 10.5 TSLP IL5 IL4 IL13 CCL11
325 fanconi anemia, complementation group e 10.5
326 leukocyte disease 10.5 IL5 IL4 IL13 CCL11
327 severe combined immunodeficiency, x-linked 10.5 TSLP IL4 IL13
328 legume allergy 10.5 TSLP SPINK5 IL5 IL4 IL13 FLG
329 fruit allergy 10.5 TSLP SPINK5 IL5 IL4 IL13 FLG
330 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.5
331 loeffler syndrome 10.5 IL5 IL13
332 upper respiratory tract disease 10.5 TSLP IL5 IL4 IL13
333 vasculitis 10.5
334 pompholyx 10.4
335 commensal bacterial infectious disease 10.4 IL5 IL4 IL13 DSG1
336 aspirin-induced respiratory disease 10.4 IL5 IL13
337 bronchial disease 10.4 TSLP IL5 IL4 IL13 FLG CCL17
338 autoimmune disease of skin and connective tissue 10.4 IL5 IL4 IL13 FLG DSG1
339 parasitic protozoa infectious disease 10.4 IL5 IL4 IL13
340 herpes simplex 10.4
341 aggressive periodontitis 10.4 NOD2 IL4 IL13
342 autoimmune disease of musculoskeletal system 10.4 IL5 IL4 IL13 DSG1
343 abacavir allergy 10.4 CCL17 CCL11
344 immune deficiency disease 10.4
345 cataract 10.4
346 adenoid hypertrophy 10.4 IL5 IL4
347 nose disease 10.4 TSLP IL5 IL4 IL31 IL13 FLG
348 nasal cavity disease 10.4 TSLP IL5 IL4 IL31 IL13 FLG
349 skin carcinoma 10.4
350 vulvar syringoma 10.4 FAF2 CMA1
351 cellulitis 10.4
352 herpes zoster 10.4
353 chronic meningitis 10.4 NLRP3 IL5 IL13 CCL11
354 lupus erythematosus 10.4
355 head and neck cancer 10.4
356 impetigo 10.4
357 refractory plasma cell neoplasm 10.4 CCL22 CCL17
358 integumentary system disease 10.4 TSLP IL5 IL4 IL31 IL13 FLG
359 ehlers-danlos syndrome, arthrochalasia type, 1 10.4
360 autoimmune disease of gastrointestinal tract 10.4 NOD2 NLRP3 IL5 IL4 IL13
361 primary bacterial infectious disease 10.4 NOD2 NLRP3 IL5 IL4 IL13
362 diarrhea 10.4
363 purpura 10.4
364 attention deficit-hyperactivity disorder 10.4
365 decubitus ulcer 10.4
366 salmonellosis 10.4 NOD2 NLRP3 IL4
367 retinal detachment 10.3
368 autoimmune disease of central nervous system 10.3 IL5 IL4 IL13
369 angioedema 10.3
370 nutritional deficiency disease 10.3
371 lymphoma 10.3
372 oculodentodigital dysplasia 10.3
373 ceroid lipofuscinosis, neuronal, 5 10.3
374 keratosis 10.3
375 dermatomyositis 10.3
376 48,xyyy 10.3
377 cheilitis 10.3
378 phenytoin allergy 10.3 CMA1 CCL11
379 sarcoidosis 1 10.3
380 sarcoidosis 2 10.3
381 pemphigus vulgaris, familial 10.3
382 severe cutaneous adverse reaction 10.3
383 human t-cell leukemia virus type 1 10.3
384 overgrowth syndrome 10.3
385 molluscum contagiosum 10.3
386 telangiectasis 10.3
387 sodoku disease 10.3 CCL22 CCL11
388 leukocyte adhesion deficiency, type i 10.3
389 gastrointestinal system disease 10.3
390 pityriasis versicolor 10.3
391 stomatitis 10.3
392 acquired immunodeficiency syndrome 10.3
393 anxiety 10.3
394 basal cell carcinoma 10.3
395 chickenpox 10.3
396 spondyloarthropathy 1 10.3
397 deficiency anemia 10.3
398 adult t-cell leukemia/lymphoma 10.3
399 toxic shock syndrome 10.3
400 primary agammaglobulinemia 10.3
401 systemic lupus erythematosus 1 10.3
402 vaccinia 10.3
403 granuloma annulare 10.3
404 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 10.3
405 basal cell carcinoma 1 10.3
406 children's interstitial lung disease 10.3
407 inflammatory bowel disease 1 10.2
408 covid-19 10.2
409 spinal cord disease 10.2
410 pik3ca-related overgrowth spectrum 10.2
411 pik3ca-related overgrowth syndrome 10.2
412 personality disorder 10.2
413 pyoderma gangrenosum 10.2
414 hereditary spastic paraplegia 10.2
415 blepharitis 10.2
416 spastic paraparesis 10.2
417 burkitt lymphoma 10.2
418 keratitis, hereditary 10.2
419 hypoascorbemia 10.2
420 rhabdomyosarcoma 2 10.2
421 ataxia with vitamin e deficiency 10.2
422 endocarditis 10.2
423 glomerulonephritis 10.2
424 gastritis 10.2
425 t-cell acute lymphoblastic leukemia 10.2
426 hypersensitivity vasculitis 10.2
427 alveolar echinococcosis 10.2 IL5 IL4
428 psoriatic arthritis 10.2
429 graft-versus-host disease 10.2
430 infective endocarditis 10.2
431 keratoconus 10.2
432 venous insufficiency 10.2
433 keratomalacia 10.2
434 panniculitis 10.2
435 gastric antral vascular ectasia 10.2
436 leukemia, t-cell, chronic 10.2
437 oto-palatal-digital syndrome 10.2
438 type 1 diabetes mellitus 10.2
439 lymphoma, hodgkin, classic 10.2
440 mucositis 10.2
441 hypothyroidism 10.2
442 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 10.2
443 tatton-brown-rahman syndrome 10.2
444 paronychia 10.2
445 lymphadenitis 10.2
446 agammaglobulinemia 10.2
447 systemic scleroderma 10.2
448 dermatographia 10.2
449 dilution, pigmentary 10.2
450 melanoma 10.2
451 sleep disorder 10.2
452 annular erythema 10.2
453 sjogren syndrome 10.2
454 hemophilia a 10.2
455 otitis externa 10.2
456 47 xxx syndrome 10.2
457 49, xxxxy syndrome 10.2
458 fetal anticonvulsant syndrome 10.2
459 discoid lupus erythematosus 10.2
460 dermographism, familial 10.2
461 trichohepatoenteric syndrome 1 10.2
462 major depressive disorder 10.2
463 glass syndrome 10.2
464 alcohol use disorder 10.2
465 squamous cell carcinoma 10.2
466 epidermolysis bullosa 10.2
467 connective tissue disease 10.2
468 down syndrome 10.2
469 bacteremia 2 10.2
470 inflammatory bowel disease 10.2
471 hidradenitis suppurativa 10.2
472 rheumatoid arthritis 10.1
473 progressive non-infectious anterior vertebral fusion 10.1
474 cutaneous lupus erythematosus 10.1
475 chronic venous insufficiency 10.1
476 urinary tract infection 10.1
477 severe acute respiratory syndrome 10.1
478 syphilis 10.1
479 localized scleroderma 10.1
480 amyloidosis 10.1
481 alopecia universalis congenita 10.1
482 graves disease 1 10.1
483 lymphoproliferative syndrome 10.1
484 smallpox 10.1
485 anterior cutaneous nerve entrapment syndrome 10.1
486 alcohol dependence 10.1
487 immunoglobulin e concentration, serum 10.1
488 squamous cell carcinoma, head and neck 10.1
489 myelodysplastic syndrome 10.1
490 rapidly involuting congenital hemangioma 10.1
491 tinea pedis 10.1
492 cone-rod dystrophy 2 10.1
493 lichen sclerosus et atrophicus 10.1
494 pernicious anemia 10.1
495 neurodegeneration with brain iron accumulation 2a 10.1
496 helix syndrome 10.1
497 pemphigus foliaceus 10.1
498 sarcoma 10.1
499 cicatricial pemphigoid 10.1
500 pemphigoid gestationis 10.1
501 thymoma 10.1
502 palmoplantar keratosis 10.1
503 hypokalemia 10.1
504 thyroiditis 10.1
505 pustular psoriasis 10.1
506 paresthesia 10.1
507 myositis 10.1
508 wiskott-aldrich syndrome 10.1
509 human immunodeficiency virus type 1 10.1
510 leptin deficiency or dysfunction 10.1
511 autism spectrum disorder 10.1
512 histiocytosis 10.1
513 parapsoriasis 10.1
514 parkinson disease, late-onset 10.1
515 body mass index quantitative trait locus 1 10.1
516 mastitis 10.1
517 anhidrosis 10.1
518 erysipelas 10.1
519 vascular disease 10.1
520 lymphopenia 10.1
521 arthritis 10.1
522 measles 10.1
523 neuropathy 10.1
524 bowel dysfunction 10.1
525 renal cell carcinoma, nonpapillary 10.0
526 body mass index quantitative trait locus 11 10.0
527 body mass index quantitative trait locus 9 10.0
528 body mass index quantitative trait locus 8 10.0
529 hypotrichosis 7 10.0
530 abdominal obesity-metabolic syndrome 1 10.0
531 body mass index quantitative trait locus 4 10.0
532 body mass index quantitative trait locus 10 10.0
533 neutrophilic dermatosis, acute febrile 10.0
534 body mass index quantitative trait locus 7 10.0
535 body mass index quantitative trait locus 12 10.0
536 body mass index quantitative trait locus 14 10.0
537 corneal dystrophy, posterior amorphous 10.0
538 body mass index quantitative trait locus 18 10.0
539 body mass index quantitative trait locus 19 10.0
540 body mass index quantitative trait locus 20 10.0
541 chronic ulcer of skin 10.0
542 angina pectoris 10.0
543 henoch-schoenlein purpura 10.0
544 pertussis 10.0
545 cardiovascular system disease 10.0
546 papilloma 10.0
547 hyper ige recurrent infection syndrome 1 10.0
548 turner syndrome 10.0
549 mastocytosis 10.0
550 wheat allergy 10.0
551 hypotrichosis 10.0
552 atrophic gastritis 10.0
553 functional neutrophil defect 10.0
554 breast cancer 10.0
555 kaposi sarcoma 10.0
556 leukemia, chronic lymphocytic 10.0
557 autism 10.0
558 langerhans cell histiocytosis 10.0
559 intraocular pressure quantitative trait locus 10.0
560 kawasaki disease 10.0
561 immunoglobulin alpha deficiency 10.0
562 neutropenia 10.0
563 juvenile rheumatoid arthritis 10.0
564 b-cell lymphoma 10.0
565 hyperthyroidism 10.0
566 actinic keratosis 10.0
567 demodicidosis 10.0
568 glucagonoma 10.0
569 granulomatous rosacea 10.0
570 shwartzman phenomenon 10.0
571 alopecia, androgenetic, 1 10.0
572 hashimoto thyroiditis 10.0
573 hyper-ige recurrent infection syndrome 1, autosomal dominant 10.0
574 contractures, pterygia, and spondylocarpotarsal fusion syndrome 1a 10.0
575 neuraminidase deficiency 10.0
576 toe syndactyly, telecanthus, and anogenital and renal malformations 10.0
577 stroke, ischemic 10.0
578 leukemia, chronic myeloid 10.0
579 erythema nodosum 10.0
580 protein-losing enteropathy 10.0
581 interstitial nephritis 10.0
582 thrombocytopenia 10.0
583 myeloproliferative neoplasm 10.0
584 lipid metabolism disorder 10.0
585 t-cell adult acute lymphocytic leukemia 10.0
586 wells syndrome 10.0
587 lichen amyloidosis 10.0
588 pigmentation anomaly of the skin 10.0
589 keloid disorder 10.0
590 dentinogenesis imperfecta 1 10.0
591 nail disorder, nonsyndromic congenital, 1 10.0
592 osteoporosis 10.0
593 thrombophilia due to thrombin defect 10.0
594 hyper-ige recurrent infection syndrome 2, autosomal recessive 10.0
595 myeloma, multiple 10.0
596 lymphoma, non-hodgkin, familial 10.0
597 nasopharyngeal carcinoma 10.0
598 aplastic anemia 10.0
599 leukemia, acute lymphoblastic 10.0
600 immunodeficiency, common variable, 10 10.0
601 androgenic alopecia 10.0
602 biotin deficiency 10.0
603 hereditary lymphedema i 10.0
604 lyme disease 10.0
605 nephrotic syndrome 10.0
606 miliaria 10.0
607 polyneuropathy 10.0
608 disease of mental health 10.0
609 thrombocytopenia due to platelet alloimmunization 10.0
610 hepatitis 10.0
611 pharyngitis 10.0
612 hematologic cancer 10.0
613 mood disorder 10.0
614 hypertrichosis 10.0
615 myopathy 10.0
616 eye disease 10.0
617 lung disease 10.0
618 encephalitis 10.0
619 tenosynovitis 10.0
620 polyarteritis nodosa 10.0
621 periodontal ehlers-danlos syndrome 10.0
622 guttate psoriasis 10.0
623 splenomegaly 10.0
624 dock8 immunodeficiency syndrome 10.0
625 bullous impetigo 10.0
626 hirschsprung disease 1 9.9
627 neutrophilia, hereditary 9.9
628 varicose veins 9.9
629 volvulus of midgut 9.9
630 glycogen storage disease v 9.9
631 congenital disorder of glycosylation, type iic 9.9
632 leukemia, acute myeloid 9.9
633 spastic paraplegia, ataxia, and mental retardation 9.9
634 myocardial infarction 9.9
635 bone mineral density quantitative trait locus 8 9.9
636 trichotillomania 9.9
637 bone mineral density quantitative trait locus 15 9.9
638 psoriasis 14, pustular 9.9
639 vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome 9.9
640 anaplastic large cell lymphoma 9.9
641 autosomal recessive congenital ichthyosis 9.9
642 non-alcoholic fatty liver disease 9.9
643 tonsillitis 9.9
644 familial hyperlipidemia 9.9
645 ecthyma 9.9
646 excessive tearing 9.9
647 factitious disorder 9.9
648 hepatitis c 9.9
649 iron metabolism disease 9.9
650 myelitis 9.9
651 collecting duct carcinoma 9.9
652 infertility 9.9
653 spondylitis 9.9
654 diffuse idiopathic skeletal hyperostosis 9.9
655 septic arthritis 9.9
656 periodontitis 9.9
657 myeloid leukemia 9.9
658 acute graft versus host disease 9.9
659 alopecia totalis 9.9
660 erythrokeratoderma ''en cocardes'' 9.9
661 granulocytopenia 9.9
662 oral lichen planus 9.9
663 gastroesophageal reflux 9.9
664 darier-white disease 9.9
665 hypercholesterolemia, familial, 1 9.9
666 laryngeal abductor paralysis 9.9
667 mastocytosis, cutaneous 9.9
668 obsessive-compulsive disorder 9.9
669 scleroderma, familial progressive 9.9
670 myasthenia gravis 9.9
671 helicobacter pylori infection 9.9
672 anterior segment dysgenesis 3 9.9
673 pulmonary disease, chronic obstructive 9.9
674 hepatitis c virus 9.9
675 lung cancer susceptibility 3 9.9
676 congenital lipomatous overgrowth, vascular malformations, and epidermal nevi 9.9
677 fetal encasement syndrome 9.9
678 intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies 9.9
679 ptosis 9.9
680 angular cheilitis 9.9
681 combined immunodeficiency 9.9
682 lactose intolerance 9.9
683 microcephaly 9.9
684 pulpitis 9.9
685 vitamin k deficiency bleeding 9.9
686 tinea corporis 9.9
687 primary biliary cholangitis 9.9
688 retinal perforation 9.9
689 coccidioidomycosis 9.9
690 hepatitis b 9.9
691 ectodermal dysplasia 9.9
692 thrombocytosis 9.9
693 acute kidney failure 9.9
694 chronic granulomatous disease 9.9
695 intestinal disease 9.9
696 hemolytic anemia 9.9
697 impetigo herpetiformis 9.9
698 lichen nitidus 9.9
699 lymphangitis 9.9
700 fasciitis 9.9
701 hemorrhoid 9.9
702 stat3 hyper ige syndrome 9.9
703 catastrophic antiphospholipid syndrome 9.9
704 cryopyrin-associated periodic syndrome 9.9
705 frontal fibrosing alopecia 9.9
706 papular urticaria 9.9
707 headache 9.9
708 acute generalized exanthematous pustulosis 9.9
709 apert syndrome 9.9
710 amyloidosis, primary localized cutaneous, 1 9.9
711 adermatoglyphia 9.9
712 muir-torre syndrome 9.9
713 iga nephropathy 1 9.9
714 benign chronic pemphigus 9.9
715 pityriasis rubra pilaris 9.9
716 thrombocytopenic purpura, autoimmune 9.9
717 vitreoretinopathy, neovascular inflammatory 9.9
718 enterocolitis 9.9
719 xeroderma pigmentosum, variant type 9.9
720 bazex syndrome 9.9
721 premature ovarian failure 7 9.9
722 nail disorder, nonsyndromic congenital, 9 9.9
723 membranous nephropathy 9.9
724 corticosteroid allergy 9.9
725 diffuse large b-cell lymphoma 9.9
726 peripheral t-cell lymphoma 9.9
727 polymyositis 9.9
728 parkinsonism 9.9
729 hypopyon 9.9
730 borderline personality disorder 9.9
731 gestational diabetes 9.9
732 conn's syndrome 9.9
733 gout 9.9
734 porphyria 9.9
735 skin sarcoidosis 9.9
736 kwashiorkor 9.9
737 anterior uveitis 9.9
738 adult-onset still's disease 9.9
739 cholinergic urticaria 9.9
740 hypersensitivity reaction type iii disease 9.9
741 ectropion 9.9
742 endogenous depression 9.9
743 cystitis 9.9
744 rectal benign neoplasm 9.9
745 dental caries 9.9
746 iga glomerulonephritis 9.9
747 gingivitis 9.9
748 keratoacanthoma 9.9
749 bone inflammation disease 9.9
750 mammary paget's disease 9.9
751 pulmonary fibrosis 9.9
752 arthropathy 9.9
753 thrombophlebitis 9.9
754 secondary syphilis 9.9
755 epidermolysis bullosa acquisita 9.9
756 pancreatitis 9.9
757 lice infestation 9.9
758 kidney disease 9.9
759 peripheral nervous system disease 9.9
760 reactive arthritis 9.9
761 transient hypogammaglobulinemia 9.9
762 cerebrovascular disease 9.9
763 myocarditis 9.9
764 collagen disease 9.9
765 rubella 9.9
766 cholangitis 9.9
767 irritable bowel syndrome 9.9
768 bowen's disease 9.9
769 gianotti crosti syndrome 9.9
770 pyogenic granuloma 9.9
771 systemic onset juvenile idiopathic arthritis 9.9
772 whiplash 9.9
773 posttransplant acute limbic encephalitis 9.9
774 argyria 9.9
775 chronic bilirubin encephalopathy 9.9
776 solar urticaria 9.9
777 vitreoretinopathy 9.9
778 polyendocrinopathy 9.9
779 twin-reversed arterial perfusion sequence 9.9
780 complement component 3 deficiency, autosomal recessive 9.8
781 sick building syndrome 9.8
782 junctional epidermolysis bullosa 9.8
783 complement component 3 deficiency 9.8
784 premature aging 9.8
785 lichen disease 9.8
786 apnea, obstructive sleep 9.8
787 leukemia, chronic lymphocytic 2 9.8
788 carpal tunnel syndrome 9.8
789 factor viii deficiency 9.8
790 guillain-barre syndrome, familial 9.8
791 hair whorl 9.8
792 porokeratosis 2, palmar, plantar, and disseminated type 9.8
793 raynaud disease 9.8
794 split-hand/foot malformation 1 9.8
795 digeorge syndrome 9.8
796 tobacco addiction 9.8
797 ataxia-telangiectasia 9.8
798 charge syndrome 9.8
799 choroidal dystrophy, central areolar, 1 9.8
800 pancreatic cancer 9.8
801 reticulum cell sarcoma 9.8
802 multiple congenital anomalies-neurodevelopmental syndrome, x-linked 9.8
803 ichthyosis, x-linked 9.8
804 incontinentia pigmenti 9.8
805 prostate cancer/brain cancer susceptibility 9.8
806 sickle cell anemia 9.8
807 bone mineral density quantitative trait locus 3 9.8
808 hypereosinophilic syndrome, idiopathic 9.8
809 pontocerebellar hypoplasia, type 3 9.8
810 chromosome 22q11.2 deletion syndrome, distal 9.8
811 mononeuropathy of the median nerve, mild 9.8
812 cholangitis, primary sclerosing 9.8
813 cerebellar ataxia, neuropathy, and vestibular areflexia syndrome 9.8
814 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.8
815 short stature, onychodysplasia, facial dysmorphism, and hypotrichosis 9.8
816 peripheral vascular disease 9.8
817 female breast cancer 9.8
818 sleep apnea 9.8
819 alexithymia 9.8
820 erythema elevatum diutinum 9.8
821 melanoma in congenital melanocytic nevus 9.8
822 chronic myelomonocytic leukemia 9.8
823 paraneoplastic pemphigus 9.8
824 severe covid-19 9.8
825 split hand-foot malformation 9.8
826 osteonecrosis 9.8
827 t cell deficiency 9.8
828 common variable immunodeficiency 9.8
829 leukemia 9.8
830 pancytopenia 9.8
831 dementia 9.8
832 urethritis 9.8
833 cholestasis 9.8
834 childhood type dermatomyositis 9.8
835 oral candidiasis 9.8
836 sclerosing cholangitis 9.8
837 glossitis 9.8
838 dermatomycosis 9.8
839 pericarditis 9.8
840 islet cell tumor 9.8
841 impotence 9.8
842 rectum cancer 9.8
843 hemangioma 9.8
844 larynx cancer 9.8
845 synovitis 9.8
846 acute pancreatitis 9.8
847 antiphospholipid syndrome 9.8
848 facial dermatosis 9.8
849 necrobiosis lipoidica 9.8
850 vulvitis 9.8
851 tinea capitis 9.8
852 poliomyelitis 9.8
853 epidermolysis bullosa dystrophica 9.8
854 neurotic disorder 9.8
855 liver cirrhosis 9.8
856 peptic ulcer disease 9.8
857 interdigitating dendritic cell sarcoma 9.8
858 osteoarthritis 9.8
859 polycythemia 9.8
860 reticulosarcoma 9.8
861 eating disorder 9.8
862 learning disability 9.8
863 ocular hypertension 9.8
864 cleft lip 9.8
865 pulmonary embolism 9.8
866 follicular mucinosis 9.8
867 acute myeloid leukemia with recurrent genetic anomaly 9.8
868 enteropathy-associated t-cell lymphoma 9.8
869 klebsiella infection 9.8
870 lichen planus pigmentosus 9.8
871 mycobacterium kansasii 9.8
872 pdgfrb-associated chronic eosinophilic leukemia 9.8
873 paraneoplastic syndromes 9.8
874 subacute cutaneous lupus erythematosus 9.8
875 cleft lip/palate 9.8
876 cerebrofacial arteriovenous metameric syndrome 9.8
877 isolated split hand-split foot malformation 9.8
878 gastritis, familial giant hypertrophic 9.8
879 motion sickness 9.8
880 nephrolithiasis, calcium oxalate 9.8
881 prediabetes syndrome 9.8
882 tic disorder 9.8
883 intracranial hypertension 9.8
884 pfeiffer syndrome 9.8
885 anal canal carcinoma 9.8
886 atherosclerosis susceptibility 9.8
887 carcinoid tumors, intestinal 9.8
888 ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 1 9.8
889 hypertension, essential 9.8
890 lentigines 9.8
891 melkersson-rosenthal syndrome 9.8
892 migraine with or without aura 1 9.8
893 nevus, epidermal 9.8
894 pachyonychia congenita 1 9.8
895 protoporphyria, erythropoietic, 1 9.8
896 spondylosis, cervical 9.8
897 stiff-person syndrome 9.8
898 albinism, oculocutaneous, type ii 9.8
899 fetal akinesia deformation sequence 1 9.8
900 epidermodysplasia verruciformis 1 9.8
901 hypoadrenocorticism, familial 9.8
902 papillon-lefevre syndrome 9.8
903 maple syrup urine disease 9.8
904 spondylometaphyseal dysplasia, sedaghatian type 9.8
905 nijmegen breakage syndrome 9.8
906 3-methylglutaconic aciduria, type iii 9.8
907 imerslund-grasbeck syndrome 1 9.8
908 hemophagocytic lymphohistiocytosis, familial, 1 9.8
909 short syndrome 9.8
910 testicular germ cell tumor 9.8
911 anemia, sideroblastic, 1 9.8
912 lymphoproliferative syndrome, x-linked, 1 9.8
913 gallbladder disease 1 9.8
914 scheie syndrome 9.8
915 granulomatosis with polyangiitis 9.8
916 alzheimer disease 12 9.8
917 acute promyelocytic leukemia 9.8
918 gastric cancer 9.8
919 microcephaly, epilepsy, and diabetes syndrome 1 9.8
920 olmsted syndrome 1 9.8
921 aortic valve disease 2 9.8
922 human herpesvirus 8 9.8
923 leptin receptor deficiency 9.8
924 fetal akinesia deformation sequence 2 9.8
925 fetal akinesia deformation sequence 3 9.8
926 t-cell lymphoma, subcutaneous panniculitis-like 9.8
927 hypoalphalipoproteinemia, primary, 2 9.8
928 hypertrophic scars 9.8
929 vitamin b12 deficiency 9.8
930 ductal carcinoma in situ 9.8
931 thrombosis 9.8
932 bone disease 9.8
933 mutilating palmoplantar keratoderma with periorificial keratotic plaques 9.8
934 corneal disease 9.8
935 mumps 9.8
936 pre-eclampsia 9.8
937 glucose intolerance 9.8
938 gastric ulcer 9.8
939 dirofilariasis 9.8
940 lepromatous leprosy 9.8
941 common wart 9.8
942 anogenital venereal wart 9.8
943 disseminated intravascular coagulation 9.8
944 adult respiratory distress syndrome 9.8
945 autonomic nervous system disease 9.8
946 protein-energy malnutrition 9.8
947 male infertility 9.8
948 graves' disease 9.8
949 bronchopneumonia 9.8
950 cicatricial ectropion 9.8
951 conduct disorder 9.8
952 brain cancer 9.8
953 reading disorder 9.8
954 megaloblastic anemia 9.8
955 patent foramen ovale 9.8
956 interstitial cystitis 9.8
957 viral hepatitis 9.8
958 telogen effluvium 9.8
959 autoimmune hepatitis 9.8
960 spondylosis 9.8
961 keratopathy 9.8
962 sensory peripheral neuropathy 9.8
963 endometriosis 9.8
964 cryoglobulinemia 9.8
965 pulmonary tuberculosis 9.8
966 bursitis 9.8
967 gingival overgrowth 9.8
968 proctitis 9.8
969 plague 9.8
970 acute retinal necrosis syndrome 9.8
971 retinitis 9.8
972 aortic aneurysm 9.8
973 merkel cell carcinoma 9.8
974 mouth disease 9.8
975 pancreatic adenocarcinoma 9.8
976 liver disease 9.8
977 erythrasma 9.8
978 superficial basal cell carcinoma 9.8
979 burning mouth syndrome 9.8
980 intracranial embolism 9.8
981 epidermolysis bullosa simplex 9.8
982 somatoform disorder 9.8
983 demyelinating polyneuropathy 9.8
984 pediculus humanus capitis infestation 9.8
985 paraplegia 9.8
986 transient hypogammaglobulinemia of infancy 9.8
987 inflammatory breast carcinoma 9.8
988 chronic kidney disease 9.8
989 mediastinitis 9.8
990 influenza 9.8
991 actinomycosis 9.8
992 scarlet fever 9.8
993 skin melanoma 9.8
994 diabetes mellitus 9.8
995 fatty liver disease 9.8
996 postpartum depression 9.8
997 bronchiectasis 9.8
998 yellow fever 9.8
999 bacterial conjunctivitis 9.8
1000 sickle cell disease 9.8
1001 carcinoid syndrome 9.8
1002 cutis verticis gyrata 9.8
1003 haemophilus influenzae 9.8
1004 herpes simplex encephalitis 9.8
1005 pityriasis lichenoides 9.8
1006 scleromyxedema 9.8
1007 cerebral aneurysms 9.8
1008 erythema multiforme major 9.8
1009 pemphigus erythematosus 9.8
1010 epidermal disease 9.8
1011 epithelial recurrent erosion dystrophy 9.7
1012 maturity-onset diabetes of the young, type 1 9.7
1013 lymphoma, mucosa-associated lymphoid type 9.7
1014 hypercalciuria, absorptive, 2 9.7
1015 hutchinson-gilford progeria syndrome 9.7
1016 wilms tumor 1 9.7
1017 farber lipogranulomatosis 9.7
1018 cartilage-hair hypoplasia 9.7
1019 xeroderma pigmentosum, complementation group a 9.7
1020 wilms tumor 5 9.7
1021 propionic acidemia 9.7
1022 immunodeficiency 35 9.7
1023 adiponectin, serum level of, quantitative trait locus 1 9.7
1024 osteomyelitis, sterile multifocal, with periostitis and pustulosis 9.7
1025 gaba aminotransferase deficiency 9.7
1026 yaws 9.7
1027 acute laryngopharyngitis 9.7
1028 cartilage disease 9.7
1029 hypolipoproteinemia 9.7
1030 biliary tract cancer 9.7
1031 cartilage-hair hypoplasia - anauxetic dysplasia spectrum disorders 9.7
1032 hypomyelination of early myelinating structures 9.7
1033 autoinflammatory syndrome 9.7
1034 aortic aneurysm, familial abdominal, 1 9.7
1035 amyotrophic lateral sclerosis 1 9.7
1036 ankyloblepharon-ectodermal defects-cleft lip/palate 9.7
1037 coloboma, ocular, autosomal dominant 9.7
1038 dentin dysplasia, type i 9.7
1039 type 2 diabetes mellitus 9.7
1040 multiple sclerosis 9.7
1041 dupuytren contracture 9.7
1042 rapp-hodgkin syndrome 9.7
1043 epidermoid cysts 9.7
1044 esophageal cancer 9.7
1045 immunoglobulin a deficiency 1 9.7
1046 hypertriglyceridemia 1 9.7
1047 inclusion body myositis 9.7
1048 intussusception 9.7
1049 lipomatosis, multiple 9.7
1050 capillary malformations, congenital 9.7
1051 ovarian cancer 9.7
1052 paget disease, extramammary 9.7
1053 pectus excavatum 9.7
1054 periodontitis, aggressive, 1 9.7
1055 pheochromocytoma 9.7
1056 polykaryocytosis inducer 9.7
1057 variegate porphyria 9.7
1058 keratosis, seborrheic 9.7
1059 small cell cancer of the lung 9.7
1060 temporal arteritis 9.7
1061 thrombocythemia 1 9.7
1062 trichomegaly 9.7
1063 adrenocortical carcinoma, hereditary 9.7
1064 anemia, autoimmune hemolytic 9.7
1065 apolipoprotein c-ii deficiency 9.7
1066 deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome 9.7
1067 dubowitz syndrome 9.7
1068 eosinophilic fasciitis 9.7
1069 ichthyosis, congenital, autosomal recessive 1 9.7
1070 ichthyosis, congenital, autosomal recessive 4b 9.7
1071 intracranial hypertension, idiopathic 9.7
1072 jawad syndrome 9.7
1073 mucolipidosis iv 9.7
1074 myelofibrosis 9.7
1075 ocular motor apraxia 9.7
1076 chronic recurrent multifocal osteomyelitis 9.7
1077 phenylketonuria 9.7
1078 isolated growth hormone deficiency, type ia 9.7
1079 pituitary hormone deficiency, combined, 2 9.7
1080 pseudoxanthoma elasticum 9.7
1081 peeling skin syndrome 1 9.7
1082 insulin-like growth factor i 9.7
1083 spastic ataxia, charlevoix-saguenay type 9.7
1084 arts syndrome 9.7
1085 aging 9.7
1086 suppression of tumorigenicity 12 9.7
1087 psoriasis 3 9.7
1088 hyperinsulinemic hypoglycemia, familial, 2 9.7
1089 xanthomatosis 9.7
1090 psoriasis 4 9.7
1091 aceruloplasminemia 9.7
1092 anorexia nervosa 9.7
1093 bulimia nervosa 9.7
1094 dermatofibrosarcoma protuberans 9.7
1095 celiac disease 2 9.7
1096 cone-rod synaptic disorder, congenital nonprogressive 9.7
1097 pulmonary alveolar proteinosis, acquired 9.7
1098 congenital disorder of glycosylation, type in 9.7
1099 hearing loss, noise-induced 9.7
1100 alpha-1-antitrypsin deficiency 9.7
1101 hemorrhage, intracerebral 9.7
1102 steel syndrome 9.7
1103 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.7
1104 angiosarcoma 9.7
1105 erysipeloid 9.7
1106 hemophagocytic lymphohistiocytosis 9.7
1107 tungiasis 9.7
1108 seckel syndrome 9.7
1109 chorioamnionitis 9.7
1110 marginal zone b-cell lymphoma 9.7
1111 atrioventricular block 9.7
1112 oral squamous cell carcinoma 9.7
1113 withdrawal disorder 9.7
1114 interleukin-7 receptor alpha deficiency 9.7
1115 sexual health disorder 9.7
1116 pain agnosia 9.7
1117 body dysmorphic disorder 9.7
1118 ileitis 9.7
1119 cardiac arrest 9.7
1120 zika fever 9.7
1121 cutaneous candidiasis 9.7
1122 b-lymphoblastic leukemia/lymphoma 9.7
1123 nk cell deficiency 9.7
1124 transverse myelitis 9.7
1125 diffuse gastric cancer 9.7
1126 human cytomegalovirus infection 9.7
1127 b-cell prolymphocytic leukemia 9.7
1128 central diabetes insipidus 9.7
1129 isolated ectopia lentis 9.7
1130 castleman disease 9.7
1131 psoriasis 15 9.7
1132 familial isolated trichomegaly 9.7
1133 pigmentation disease 9.7
1134 dry eye syndrome 9.7
1135 tuberculoid leprosy 9.7
1136 prolymphocytic leukemia 9.7
1137 bacterial infectious disease 9.7
1138 osteomalacia 9.7
1139 allergic urticaria 9.7
1140 open-angle glaucoma 9.7
1141 hypertrophy of breast 9.7
1142 giardiasis 9.7
1143 multiple personality disorder 9.7
1144 myiasis 9.7
1145 miliaria rubra 9.7
1146 acute conjunctivitis 9.7
1147 angelucci's syndrome 9.7
1148 arteriovenous malformation 9.7
1149 pneumocystosis 9.7
1150 limb-girdle muscular dystrophy 9.7
1151 iron deficiency anemia 9.7
1152 multicentric reticulohistiocytosis 9.7
1153 myopia 9.7
1154 visual epilepsy 9.7
1155 peripheral retinal degeneration 9.7
1156 goiter 9.7
1157 punctate epithelial keratoconjunctivitis 9.7
1158 vulva cancer 9.7
1159 secondary hyperparathyroidism 9.7
1160 bell's palsy 9.7
1161 acute kidney tubular necrosis 9.7
1162 olecranon bursitis 9.7
1163 ancylostomiasis 9.7
1164 guillain-barre syndrome 9.7
1165 hypochondriasis 9.7
1166 dilated cardiomyopathy 9.7
1167 tinea unguium 9.7
1168 ehlers-danlos syndrome 9.7
1169 hyperparathyroidism 9.7
1170 sick sinus syndrome 9.7
1171 somatization disorder 9.7
1172 amenorrhea 9.7
1173 autoimmune polyendocrine syndrome 9.7
1174 anus cancer 9.7
1175 bacteriuria 9.7
1176 dumping syndrome 9.7
1177 geographic tongue 9.7
1178 root resorption 9.7
1179 cholera 9.7
1180 rheumatic fever 9.7
1181 heart septal defect 9.7
1182 endocrine gland cancer 9.7
1183 histoplasmosis 9.7
1184 status epilepticus 9.7
1185 epilepsy 9.7
1186 cholecystitis 9.7
1187 cerebral palsy 9.7
1188 hyperinsulinism 9.7
1189 atypical teratoid rhabdoid tumor 9.7
1190 vaginitis 9.7
1191 carbuncle 9.7
1192 essential thrombocythemia 9.7
1193 vulvovaginitis 9.7
1194 lateral sclerosis 9.7
1195 polyclonal hypergammaglobulinemia 9.7
1196 arteriosclerosis 9.7
1197 relapsing-remitting multiple sclerosis 9.7
1198 neonatal jaundice 9.7
1199 splenic infarction 9.7
1200 relapsing polychondritis 9.7
1201 laryngeal benign neoplasm 9.7
1202 benign mesothelioma 9.7
1203 capillary hemangioma 9.7
1204 hemoglobinopathy 9.7
1205 adenocarcinoma 9.7
1206 germ cell cancer 9.7
1207 testicular cancer 9.7
1208 breast ductal carcinoma 9.7
1209 substance abuse 9.7
1210 cutis laxa 9.7
1211 skin squamous cell carcinoma 9.7
1212 monkeypox 9.7
1213 bipolar disorder 9.7
1214 fibrosarcoma 9.7
1215 signet ring cell adenocarcinoma 9.7
1216 toxic encephalopathy 9.7
1217 plasmacytoma 9.7
1218 anovulation 9.7
1219 pleural empyema 9.7
1220 porokeratosis 9.7
1221 lung squamous cell carcinoma 9.7
1222 angioma serpiginosum 9.7
1223 primary syphilis 9.7
1224 hyperglycemia 9.7
1225 polyradiculoneuropathy 9.7
1226 pustulosis of palm and sole 9.7
1227 cutaneous fibrous histiocytoma 9.7
1228 seminoma 9.7
1229 proliferative glomerulonephritis 9.7
1230 movement disease 9.7
1231 esophagus adenocarcinoma 9.7
1232 chronic inflammatory demyelinating polyradiculoneuropathy 9.7
1233 human immunodeficiency virus infectious disease 9.7
1234 hydrarthrosis 9.7
1235 anal squamous cell carcinoma 9.7
1236 compartment syndrome 9.7
1237 premenstrual tension 9.7
1238 muscular atrophy 9.7
1239 neuroblastoma 9.7
1240 appendicitis 9.7
1241 corneal ulcer 9.7
1242 retinal degeneration 9.7
1243 whipple disease 9.7
1244 mucormycosis 9.7
1245 monocytic leukemia 9.7
1246 chronic fatigue syndrome 9.7
1247 multiple carboxylase deficiency 9.7
1248 duodenitis 9.7
1249 gastroduodenitis 9.7
1250 genital herpes 9.7
1251 diabetes insipidus 9.7
1252 babesiosis 9.7
1253 neonatal abstinence syndrome 9.7
1254 refractive error 9.7
1255 meibomian cyst 9.7
1256 hypoglycemia 9.7
1257 actinic lichen planus 9.7
1258 aminoaciduria 9.7
1259 bowenoid papulosis 9.7
1260 chronic graft versus host disease 9.7
1261 cutaneous sclerosis 9.7
1262 grover's disease 9.7
1263 inflammatory linear verrucous epidermal nevus 9.7
1264 lip and oral cavity cancer 9.7
1265 mycobacterium marinum 9.7
1266 neonatal systemic lupus erythematosus 9.7
1267 progressive encephalomyelitis with rigidity and myoclonus 9.7
1268 pyridoxine deficiency 9.7
1269 staphylococcal toxic shock syndrome 9.7
1270 encephalopathy 9.7
1271 pituitary tumors 9.7
1272 syncope 9.7
1273 folliculotropic mycosis fungoides 9.7
1274 systemic autoimmune disease 9.7
1275 primary cutaneous lymphoma 9.7
1276 germ cell tumor 9.7
1277 acquired cutis laxa 9.7
1278 diffuse palmoplantar keratoderma 9.7
1279 primary cutaneous anaplastic large cell lymphoma 9.7
1280 neonatal lupus erythematosus 9.7
1281 acquired ichthyosis 9.7
1282 rare genetic skin disease 9.7
1283 inherited epidermolysis bullosa 9.7
1284 heiner syndrome 9.7
1285 precursor t-cell acute lymphoblastic leukemia 9.7
1286 aniridia 1 9.6
1287 preauricular fistulae, congenital 9.6
1288 multiple endocrine neoplasia, type i 9.6
1289 eosinophilia, familial 9.6
1290 heinz body anemias 9.6
1291 keratitis-ichthyosis-deafness syndrome, autosomal dominant 9.6
1292 cyclic neutropenia 9.6
1293 paget disease of bone 3 9.6
1294 palatopharyngeal incompetence 9.6
1295 velocardiofacial syndrome 9.6
1296 schopf-schulz-passarge syndrome 9.6
1297 galactorrhea 9.6
1298 glaucoma 3, primary congenital, a 9.6
1299 ciliary dyskinesia, primary, 1 9.6
1300 letterer-siwe disease 9.6
1301 shwachman-diamond syndrome 1 9.6
1302 spondyloepimetaphyseal dysplasia, sponastrime type 9.6
1303 anemia, sideroblastic, and spinocerebellar ataxia 9.6
1304 menkes disease 9.6
1305 reticuloendotheliosis, x-linked 9.6
1306 rett syndrome 9.6
1307 cervical cancer 9.6
1308 resting heart rate, variation in 9.6
1309 mycobacterium tuberculosis 1 9.6
1310 lipodystrophy, congenital generalized, type 1 9.6
1311 thiopurines, poor metabolism of, 1 9.6
1312 hyperprolactinemia 9.6
1313 lung disease, immunodeficiency, and chromosome breakage syndrome 9.6
1314 shrimp allergy 9.6
1315 oxirane allergy 9.6
1316 kartagener syndrome 9.6
1317 brugada syndrome 9.6
1318 oculocutaneous albinism 9.6
1319 spondyloepimetaphyseal dysplasia 9.6
1320 urolithiasis 9.6
1321 lactocele 9.6
1322 meningocele 9.6
1323 obsessive-compulsive personality disorder 9.6
1324 bullous keratopathy 9.6
1325 horner's syndrome 9.6
1326 hepatorenal syndrome 9.6
1327 blastomycosis 9.6
1328 klebsiella pneumonia 9.6
1329 hepatic encephalopathy 9.6
1330 eclampsia 9.6
1331 pthirus pubis infestation 9.6
1332 prostatitis 9.6
1333 branchiootorenal syndrome 9.6
1334 arthus reaction 9.6
1335 clear cell acanthoma 9.6
1336 duodenal ulcer 9.6
1337 acanthoma 9.6
1338 tularemia 9.6
1339 acromegaly 9.6
1340 hemangioma of liver 9.6
1341 carbohydrate metabolic disorder 9.6
1342 bacterial vaginosis 9.6
1343 insulinoma 9.6
1344 femoral neuropathy 9.6
1345 hair disease 9.6
1346 skin angiosarcoma 9.6
1347 subacute bacterial endocarditis 9.6
1348 atrophic rhinitis 9.6
1349 paget's disease of bone 9.6
1350 nephrolithiasis 9.6
1351 viral encephalitis 9.6
1352 mitochondrial myopathy 9.6
1353 monoclonal gammopathy of uncertain significance 9.6
1354 situs inversus 9.6
1355 pyomyositis 9.6
1356 intermediate coronary syndrome 9.6
1357 amebiasis 9.6
1358 amino acid metabolic disorder 9.6
1359 homocystinuria 9.6
1360 primary ciliary dyskinesia 9.6
1361 necrotizing fasciitis 9.6
1362 steroid-induced glaucoma 9.6
1363 tp63-related disorders 9.6
1364 49,xxxxx syndrome 9.6
1365 albinism 9.6
1366 cervical intraepithelial neoplasia 9.6
1367 congenital herpes simplex 9.6
1368 cytomegalic inclusion disease 9.6
1369 dextrocardia with situs inversus 9.6
1370 ichthyosis linearis circumflexa 9.6
1371 immunoglobulin g deficiency 9.6
1372 preauricular sinus 9.6
1373 rare tumor of pancreas 9.6
1374 inherited ichthyosis 9.6
1375 inflammatory myopathy with abundant macrophages 9.6
1376 lmna-related cardiocutaneous progeria syndrome 9.6
1377 hyperpigmentation of the skin 9.6
1378 microtia 9.6
1379 abducens palsy 9.5
1380 acanthosis nigricans 9.5
1381 acromegaloid changes, cutis verticis gyrata, and corneal leukoma 9.5
1382 severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency 9.5
1383 ainhum 9.5
1384 diamond-blackfan anemia 1 9.5
1385 arteries, anomalies of 9.5
1386 aortic valve disease 1 9.5
1387 bladder cancer 9.5
1388 epidermolytic hyperkeratosis 9.5
1389 campomelic dysplasia 9.5
1390 cleft palate, isolated 9.5
1391 blepharocheilodontic syndrome 1 9.5
1392 coloboma of macula 9.5
1393 coloboma of optic nerve 9.5
1394 craniofacial-deafness-hand syndrome 9.5
1395 cryoglobulinemia, familial mixed 9.5
1396 epidermolysis bullosa dystrophica, autosomal dominant 9.5
1397 epidermolysis bullosa simplex 1a, generalized severe 9.5
1398 erythrokeratodermia variabilis et progressiva 1 9.5
1399 fibrinolytic defect 9.5
1400 fibrodysplasia ossificans progressiva 9.5
1401 fucosidase regulator 9.5
1402 melanocytic nevus syndrome, congenital 9.5
1403 glioma susceptibility 1 9.5
1404 hair morphology 2 9.5
1405 hawkinsinuria 9.5
1406 palmoplantar keratoderma, epidermolytic 9.5
1407 endosteal hyperostosis, autosomal dominant 9.5
1408 hypertelorism 9.5
1409 keloid formation 9.5
1410 legg-calve-perthes disease 9.5
1411 leopard syndrome 1 9.5
1412 leukemia, acute monocytic 9.5
1413 nail disorder, nonsyndromic congenital, 3 9.5
1414 macular dystrophy, dominant cystoid 9.5
1415 marfan syndrome 9.5
1416 medulloblastoma 9.5
1417 melanoma, uveal 9.5
1418 melanoma-astrocytoma syndrome 9.5
1419 meniere disease 9.5
1420 mesothelioma, malignant 9.5
1421 naegeli-franceschetti-jadassohn syndrome 9.5
1422 nail-patella syndrome 9.5
1423 narcolepsy 1 9.5
1424 neurofibromatosis, type i 9.5
1425 schimmelpenning-feuerstein-mims syndrome 9.5
1426 noonan syndrome 1 9.5
1427 ocular cicatricial pemphigoid 9.5
1428 spinocerebellar ataxia 1 9.5
1429 pancreatitis, hereditary 9.5
1430 papillomatosis, confluent and reticulated 9.5
1431 paragangliomas 1 9.5
1432 prolidase deficiency 9.5
1433 pick disease of brain 9.5
1434 polydactyly, postaxial, type a1 9.5
1435 popliteal cyst 9.5
1436 porphyria, acute intermittent 9.5
1437 prostate cancer 9.5
1438 liddle syndrome 1 9.5
1439 pulmonary hemosiderosis 9.5
1440 pulmonary hypertension, primary, 1 9.5
1441 pruritic urticarial papules and plaques of pregnancy 9.5
1442 aplasia of lacrimal and salivary glands 9.5
1443 scalp-ear-nipple syndrome 9.5
1444 neural tube defects 9.5
1445 spondylolisthesis 9.5
1446 steatocystoma multiplex 9.5
1447 strabismus 9.5
1448 sturge-weber syndrome 9.5
1449 supravalvular aortic stenosis 9.5
1450 chromosome 2q35 duplication syndrome 9.5
1451 thyroid cancer, nonmedullary, 1 9.5
1452 trichodentoosseous syndrome 9.5
1453 suppressor of tumorigenicity 3 9.5
1454 uncombable hair syndrome 1 9.5
1455 urticaria, aquagenic 9.5
1456 vasculitis, lymphocytic, nodular 9.5
1457 alkaptonuria 9.5
1458 takayasu arteritis 9.5
1459 arthrogryposis, renal dysfunction, and cholestasis 1 9.5
1460 central hypoventilation syndrome, congenital, 1 9.5
1461 cholestasis, progressive familial intrahepatic, 1 9.5
1462 c syndrome 9.5
1463 lung cancer 9.5
1464 joubert syndrome 1 9.5
1465 dyssynergia cerebellaris myoclonica of hunt 9.5
1466 chediak-higashi syndrome 9.5
1467 complement component 2 deficiency 9.5
1468 costello syndrome 9.5
1469 hypothyroidism, congenital, nongoitrous, 2 9.5
1470 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 9.5
1471 factor vii deficiency 9.5
1472 fanconi anemia, complementation group d2 9.5
1473 3-hydroxyacyl-coa dehydrogenase deficiency 9.5
1474 goodpasture syndrome 9.5
1475 factor xii deficiency 9.5
1476 trichothiodystrophy 4, nonphotosensitive 9.5
1477 halo nevi 9.5
1478 hartnup disorder 9.5
1479 hemochromatosis, type 1 9.5
1480 histidinemia 9.5
1481 hutterite cerebroosteonephrodysplasia syndrome 9.5
1482 hypogonadism, male 9.5
1483 acetylation, slow 9.5
1484 arima syndrome 9.5
1485 lipoid proteinosis of urbach and wiethe 9.5
1486 mucolipidosis ii alpha/beta 9.5
1487 lethal congenital contracture syndrome 1 9.5
1488 muscular dystrophy, limb-girdle, autosomal recessive 5 9.5
1489 myeloperoxidase deficiency 9.5
1490 myxedema 9.5
1491 gyrate atrophy of choroid and retina 9.5
1492 osteogenic sarcoma 9.5
1493 peters-plus syndrome 9.5
1494 glycogen storage disease ixb 9.5
1495 pili torti, early-onset 9.5
1496 scott syndrome 9.5
1497 polycythemia vera 9.5
1498 multiple pterygium syndrome, escobar variant 9.5
1499 autoimmune polyendocrine syndrome, type ii 9.5
1500 smith-lemli-opitz syndrome 9.5
1501 taurodontism 9.5
1502 thymoma, familial 9.5
1503 hypothyroidism, congenital, nongoitrous, 1 9.5
1504 tinea imbricata 9.5
1505 methylmalonic aciduria and homocystinuria, cblc type 9.5
1506 waardenburg syndrome, type 4a 9.5
1507 wilson disease 9.5
1508 woolly hair, hypotrichosis, everted lower lip, and outstanding ears 9.5
1509 coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation, and ear anomalies syndrome 9.5
1510 opitz gbbb syndrome 9.5
1511 fragile x syndrome 9.5
1512 chromosome xp21 deletion syndrome 9.5
1513 chondrodysplasia punctata 2, x-linked dominant 9.5
1514 aarskog-scott syndrome 9.5
1515 granulomatous disease, chronic, x-linked 9.5
1516 glycerol kinase deficiency 9.5
1517 hypogonadotropic hypogonadism 1 with or without anosmia 9.5
1518 linear skin defects with multiple congenital anomalies 1 9.5
1519 muscular dystrophy, duchenne type 9.5
1520 thoracoabdominal syndrome 9.5
1521 alzheimer disease mitochondrial 9.5
1522 kearns-sayre syndrome 9.5
1523 prostatic hyperplasia, benign 9.5
1524 epilepsy, childhood absence 1 9.5
1525 retinitis pigmentosa 11 9.5
1526 aminopterin syndrome sine aminopterin 9.5
1527 loose anagen hair syndrome 9.5
1528 budd-chiari syndrome 9.5
1529 brody disease 9.5
1530 cd4/cd8 t-cell ratio 9.5
1531 dental anomalies and short stature 9.5
1532 neurofibromatosis-noonan syndrome 9.5
1533 retinitis pigmentosa 18 9.5
1534 inflammatory bowel disease 2 9.5
1535 athabaskan brainstem dysgenesis syndrome 9.5
1536 neural tube defects, folate-sensitive 9.5
1537 suppressor of tumorigenicity 11 9.5
1538 hyperhomocysteinemia 9.5
1539 polydactyly 9.5
1540 urinary tract infections, recurrent 9.5
1541 brittle bone disorder 9.5
1542 ventricular fibrillation, paroxysmal familial, 1 9.5
1543 intervertebral disc disease 9.5
1544 microvascular complications of diabetes 1 9.5
1545 epidermolysis bullosa pruriginosa 9.5
1546 chudley-mccullough syndrome 9.5
1547 psoriasis 5 9.5
1548 becker nevus syndrome 9.5
1549 glycine encephalopathy 9.5
1550 phelan-mcdermid syndrome 9.5
1551 mental retardation, microcephaly, growth retardation, joint contractures, and facial dysmorphism 9.5
1552 huntington disease-like 2 9.5
1553 gastrointestinal stromal tumor 9.5
1554 glucose/galactose malabsorption 9.5
1555 meningioma, familial 9.5
1556 celiac disease 5 9.5
1557 hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration 9.5
1558 coronary heart disease 1 9.5
1559 patent ductus arteriosus 1 9.5
1560 niemann-pick disease, type c2 9.5
1561 hypertensive nephropathy 9.5
1562 aica-ribosuria due to atic deficiency 9.5
1563 ichthyosis with confetti 9.5
1564 loeys-dietz syndrome 1 9.5
1565 celiac disease 4 9.5
1566 hypothyroidism, congenital, nongoitrous, 3 9.5
1567 corneal dystrophy, congenital stromal 9.5
1568 alcohol sensitivity, acute 9.5
1569 psoriasis 8 9.5
1570 epilepsy, idiopathic generalized 13 9.5
1571 malaria 9.5
1572 celiac disease 10 9.5
1573 celiac disease 12 9.5
1574 ewing sarcoma 9.5
1575 immunodeficiency 68 9.5
1576 pseudofolliculitis barbae 9.5
1577 congenital disorder of glycosylation, type iq 9.5
1578 psoriasis 10 9.5
1579 factor xi deficiency 9.5
1580 immunodeficiency 10 9.5
1581 macs syndrome 9.5
1582 muscular dystrophy, congenital, lmna-related 9.5
1583 waardenburg syndrome, type 4b 9.5
1584 waardenburg syndrome, type 4c 9.5
1585 fatty liver disease 1 9.5
1586 muscle hypertrophy 9.5
1587 mannose-binding lectin deficiency 9.5
1588 pregnancy loss, recurrent 1 9.5
1589 familial cold autoinflammatory syndrome 3 9.5
1590 meconium ileus 9.5
1591 cataract 38 9.5
1592 short stature, optic nerve atrophy, and pelger-huet anomaly 9.5
1593 microcephaly, short stature, and polymicrogyria with or without seizures 9.5
1594 riboflavin deficiency 9.5
1595 facial dysmorphism, immunodeficiency, livedo, and short stature 9.5
1596 leukemia, acute lymphoblastic 3 9.5
1597 immunodeficiency 19 9.5
1598 cholangiocarcinoma 9.5
1599 cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis 9.5
1600 glucocorticoid resistance, generalized 9.5
1601 analbuminemia 9.5
1602 immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation 9.5
1603 thrombocytopenia 5 9.5
1604 hyperlipoproteinemia, type iii 9.5
1605 mulchandani-bhoj-conlin syndrome 9.5
1606 central centrifugal cicatricial alopecia 9.5
1607 aortic valve disease 3 9.5
1608 pancreatic cancer 5 9.5
1609 lipoprotein quantitative trait locus 9.5
1610 iron overload 9.5
1611 peyronie's disease 9.5
1612 chlorhexidine allergy 9.5
1613 autoimmune gastritis 9.5
1614 autoimmune pancreatitis 9.5
1615 superficial mycosis 9.5
1616 acute diarrhea 9.5
1617 aspiration pneumonia 9.5
1618 cryptogenic organizing pneumonia 9.5
1619 lambert-eaton myasthenic syndrome 9.5
1620 granulomatous amebic encephalitis 9.5
1621 fusariosis 9.5
1622 familial adenomatous polyposis 9.5
1623 restless legs syndrome 9.5
1624 usher syndrome 9.5
1625 lissencephaly 9.5
1626 periventricular nodular heterotopia 9.5
1627 loeys-dietz syndrome 9.5
1628 epidemic typhus 9.5
1629 variola major 9.5
1630 funisitis 9.5
1631 metabolic acidosis 9.5
1632 progressive relapsing multiple sclerosis 9.5
1633 third-degree atrioventricular block 9.5
1634 rheumatic heart disease 9.5
1635 peripheral artery disease 9.5
1636 limb ischemia 9.5
1637 oppositional defiant disorder 9.5
1638 colorectal adenocarcinoma 9.5
1639 fibroma 9.5
1640 ovarian serous carcinoma 9.5
1641 breast lobular carcinoma 9.5
1642 microscopic colitis 9.5
1643 jejunoileitis 9.5
1644 atrial fibrillation 9.5
1645 scoliosis 9.5
1646 gallbladder disease 9.5
1647 persistent generalized lymphadenopathy 9.5
1648 oral hairy leukoplakia 9.5
1649 inguinal hernia 9.5
1650 umbilical hernia 9.5
1651 breast abscess 9.5
1652 acrodermatitis chronica atrophicans 9.5
1653 chromosome 1p36 deletion syndrome 9.5
1654 purpura fulminans 9.5
1655 lethal congenital contracture syndrome 9.5
1656 spinal disease 9.5
1657 congenital central hypoventilation syndrome 9.5
1658 griscelli syndrome 9.5
1659 isolated growth hormone deficiency 9.5
1660 progressive familial intrahepatic cholestasis 9.5
1661 primary autosomal recessive microcephaly 9.5
1662 primary microcephaly 9.5
1663 miliaria pustulosa 9.5
1664 cerebellar hypoplasia 9.5
1665 physical disorder 9.5
1666 cryptococcal meningitis 9.5
1667 polycystic kidney disease 9.5
1668 x-linked chondrodysplasia punctata 2 9.5
1669 chronic eosinophilic leukemia 9.5
1670 non-alcoholic steatohepatitis 9.5
1671 tongue carcinoma 9.5
1672 polymicrogyria 9.5
1673 serum amyloid a amyloidosis 9.5
1674 nonobstructive coronary artery disease 9.5
1675 non-severe covid-19 9.5
1676 t-cell prolymphocytic leukemia 9.5
1677 acute myelomonocytic leukemia 9.5
1678 familial woolly hair syndrome 9.5
1679 familial adult myoclonic epilepsy 9.5
1680 sensorineural hearing loss 9.5
1681 endometritis 9.5
1682 intracranial abscess 9.5
1683 sleeping sickness 9.5
1684 ehrlichiosis 9.5
1685 otorrhea 9.5
1686 berylliosis 9.5
1687 blepharophimosis 9.5
1688 amblyopia 9.5
1689 meningoencephalitis 9.5
1690 blind loop syndrome 9.5
1691 microphthalmia 9.5
1692 thrombotic thrombocytopenic purpura 9.5
1693 mesenteric lymphadenitis 9.5
1694 methemoglobinemia 9.5
1695 hand, foot and mouth disease 9.5
1696 dissociative disorder 9.5
1697 impulse control disorder 9.5
1698 lipoid nephrosis 9.5
1699 spastic hemiplegia 9.5
1700 hemiplegia 9.5
1701 corneal edema 9.5
1702 leech infestation 9.5
1703 hydronephrosis 9.5
1704 hypoparathyroidism 9.5
1705 acute contagious conjunctivitis 9.5
1706 acute hemorrhagic conjunctivitis 9.5
1707 spondyloarthropathy 9.5
1708 orbital cellulitis 9.5
1709 microcytic anemia 9.5
1710 rabies 9.5
1711 lens subluxation 9.5
1712 pulmonary edema 9.5
1713 heart disease 9.5
1714 constrictive pericarditis 9.5
1715 cardiac tamponade 9.5
1716 mitral valve insufficiency 9.5
1717 suppurative otitis media 9.5
1718 fissured tongue 9.5
1719 hypertensive heart disease 9.5
1720 corneal deposit 9.5
1721 hyperandrogenism 9.5
1722 palindromic rheumatism 9.5
1723 portal vein thrombosis 9.5
1724 denture stomatitis 9.5
1725 tinea cruris 9.5
1726 panuveitis 9.5
1727 cryptococcosis 9.5
1728 hemosiderosis 9.5
1729 dysthymic disorder 9.5
1730 aseptic meningitis 9.5
1731 superficial keratitis 9.5
1732 vogt-koyanagi-harada disease 9.5
1733 dysentery 9.5
1734 entropion 9.5
1735 pathological gambling 9.5
1736 capillariasis 9.5
1737 hepatitis a 9.5
1738 paracoccidioidomycosis 9.5
1739 vestibular neuronitis 9.5
1740 leiomyoma 9.5
1741 enterocele 9.5
1742 choreatic disease 9.5
1743 keratoconjunctivitis sicca 9.5
1744 central retinal artery occlusion 9.5
1745 crescentic glomerulonephritis 9.5
1746 nontoxic goiter 9.5
1747 exocrine pancreatic insufficiency 9.5
1748 congenital toxoplasmosis 9.5
1749 tinea manuum 9.5
1750 scrub typhus 9.5
1751 pure red-cell aplasia 9.5
1752 scleritis 9.5
1753 alveolar periostitis 9.5
1754 sapho syndrome 9.5
1755 mature cataract 9.5
1756 fox-fordyce disease 9.5
1757 familial hypercholesterolemia 9.5
1758 white piedra 9.5
1759 small intestine lymphoma 9.5
1760 poems syndrome 9.5
1761 phaeohyphomycosis 9.5
1762 iritis 9.5
1763 acute poststreptococcal glomerulonephritis 9.5
1764 plasmodium falciparum malaria 9.5
1765 epicondylitis 9.5
1766 renal tubular acidosis 9.5
1767 ochronosis 9.5
1768 azoospermia 9.5
1769 chronic purulent otitis media 9.5
1770 primary hypertrophic osteoarthropathy 9.5
1771 noonan syndrome with multiple lentigines 9.5
1772 generalized anxiety disorder 9.5
1773 postencephalitic parkinson disease 9.5
1774 pyuria 9.5
1775 dracunculiasis 9.5
1776 sporotrichosis 9.5
1777 niemann-pick disease 9.5
1778 candidal paronychia 9.5
1779 reye syndrome 9.5
1780 hereditary angioedema 9.5
1781 lymphangioma 9.5
1782 gingival disease 9.5
1783 limited scleroderma 9.5
1784 diffuse scleroderma 9.5
1785 ventricular septal defect 9.5
1786 retinal vein occlusion 9.5
1787 cryptosporidiosis 9.5
1788 pancreatic endocrine carcinoma 9.5
1789 urinary system disease 9.5
1790 neuroendocrine carcinoma 9.5
1791 neuritis 9.5
1792 intrahepatic cholestasis 9.5
1793 atrial heart septal defect 9.5
1794 optic nerve disease 9.5
1795 noninfectious dermatoses of eyelid 9.5
1796 malignant fibrous histiocytoma 9.5
1797 hyperuricemia 9.5
1798 hypogonadism 9.5
1799 fallopian tube carcinoma 9.5
1800 leiomyosarcoma 9.5
1801 hyperostosis 9.5
1802 chronic mucocutaneous candidiasis 9.5
1803 cystoisosporiasis 9.5
1804 coccidiosis 9.5
1805 granulomatous hepatitis 9.5
1806 ankylosis 9.5
1807 capillary lymphangioma 9.5
1808 leptospirosis 9.5
1809 nocardiosis 9.5
1810 colon adenocarcinoma 9.5
1811 craniosynostosis 9.5
1812 macrocytic anemia 9.5
1813 glomus tumor 9.5
1814 central retinal vein occlusion 9.5
1815 protein s deficiency 9.5
1816 psychotic disorder 9.5
1817 orchitis 9.5
1818 kidney cancer 9.5
1819 pigmented villonodular synovitis 9.5
1820 phimosis 9.5
1821 bilirubin metabolic disorder 9.5
1822 glycogen storage disease 9.5
1823 bronchiolitis obliterans 9.5
1824 acquired polycythemia 9.5
1825 euthyroid sick syndrome 9.5
1826 membranoproliferative glomerulonephritis 9.5
1827 periarthritis 9.5
1828 kidney papillary necrosis 9.5
1829 anuria 9.5
1830 mucinous adenocarcinoma 9.5
1831 ascaridiasis 9.5
1832 serous cystadenocarcinoma 9.5
1833 gallbladder cancer 9.5
1834 anus disease 9.5
1835 scalp dermatosis 9.5
1836 tenosynovial giant cell tumor 9.5
1837 scleredema adultorum 9.5
1838 mucinoses 9.5
1839 lipomatosis 9.5
1840 hand dermatosis 9.5
1841 skin benign neoplasm 9.5
1842 skin papilloma 9.5
1843 complex regional pain syndrome 9.5
1844 syringomyelia 9.5
1845 mixed germ cell cancer 9.5
1846 teratoma 9.5
1847 angiomyolipoma 9.5
1848 laryngitis 9.5
1849 systemic mastocytosis 9.5
1850 superior mesenteric artery syndrome 9.5
1851 appendix adenocarcinoma 9.5
1852 kallmann syndrome 9.5
1853 mast cell neoplasm 9.5
1854 cervical adenocarcinoma 9.5
1855 ovary adenocarcinoma 9.5
1856 gastric adenocarcinoma 9.5
1857 verrucous carcinoma 9.5
1858 vaginal discharge 9.5
1859 acute myocarditis 9.5
1860 lymphocytic gastritis 9.5
1861 tick infestation 9.5
1862 nail disease 9.5
1863 biliary dyskinesia 9.5
1864 carcinosarcoma 9.5
1865 coronary stenosis 9.5
1866 ebola hemorrhagic fever 9.5
1867 erdheim-chester disease 9.5
1868 non-langerhans-cell histiocytosis 9.5
1869 amelanotic melanoma 9.5
1870 neuromuscular disease 9.5
1871 fibrous histiocytoma 9.5
1872 somatostatinoma 9.5
1873 pancreatic somatostatinoma 9.5
1874 dysgerminoma 9.5
1875 breast angiosarcoma 9.5
1876 conventional angiosarcoma 9.5
1877 bile duct cancer 9.5
1878 uremia 9.5
1879 endophthalmitis 9.5
1880 calciphylaxis 9.5
1881 sebaceous adenocarcinoma 9.5
1882 small intestine adenocarcinoma 9.5
1883 myelodysplastic/myeloproliferative neoplasm 9.5
1884 essential tremor 9.5
1885 basosquamous carcinoma 9.5
1886 adjustment disorder 9.5
1887 thoracic cancer 9.5
1888 aortitis 9.5
1889 gingival hypertrophy 9.5
1890 dystonia 9.5
1891 eccrine acrospiroma 9.5
1892 spiradenoma 9.5
1893 mediastinal cancer 9.5
1894 retinal disease 9.5
1895 adenosine deaminase deficiency 9.5
1896 hemoglobinuria 9.5
1897 gray zone lymphoma 9.5
1898 silent myocardial infarction 9.5
1899 panic disorder 9.5
1900 congestive heart failure 9.5
1901 blood protein disease 9.5
1902 chronic lymphocytic leukemia/small lymphocytic lymphoma 9.5
1903 acral lentiginous melanoma 9.5
1904 progressive multifocal leukoencephalopathy 9.5
1905 bilateral breast cancer 9.5
1906 mediastinal gray zone lymphoma 9.5
1907 skin tag 9.5
1908 anal canal squamous cell carcinoma 9.5
1909 malignant pleural mesothelioma 9.5
1910 lymphatic system disease 9.5
1911 childhood leukemia 9.5
1912 delusional disorder 9.5
1913 end stage renal disease 9.5
1914 tertiary syphilis 9.5
1915 trombiculiasis 9.5
1916 kidney angiomyolipoma 9.5
1917 intestinal obstruction 9.5
1918 ileus 9.5
1919 retinal artery occlusion 9.5
1920 rheumatoid arthritis interstitial lung disease 9.5
1921 fundus dystrophy 9.5
1922 chronic monocytic leukemia 9.5
1923 neurofibromatosis 9.5
1924 vascular dementia 9.5
1925 milker's nodule 9.5
1926 metagonimiasis 9.5
1927 neuromyelitis optica 9.5
1928 evans' syndrome 9.5
1929 cowpox 9.5
1930 narcolepsy 9.5
1931 cervix uteri carcinoma in situ 9.5
1932 degenerative disc disease 9.5
1933 gastrointestinal lymphoma 9.5
1934 macroglobulinemia 9.5
1935 gas gangrene 9.5
1936 speech disorder 9.5
1937 periodic limb movement disorder 9.5
1938 herpes zoster oticus 9.5
1939 erythromelalgia 9.5
1940 waardenburg's syndrome 9.5
1941 priapism 9.5
1942 scotoma 9.5
1943 croup 9.5
1944 hypopituitarism 9.5
1945 acute myocardial infarction 9.5
1946 plantar fasciitis 9.5
1947 neurofibroma 9.5
1948 pathologic nystagmus 9.5
1949 aphthous stomatitis 9.5
1950 senile cataract 9.5
1951 ulcerative stomatitis 9.5
1952 pulmonary emphysema 9.5
1953 purulent endophthalmitis 9.5
1954 diabetic neuropathy 9.5
1955 congenital syphilis 9.5
1956 muscular dystrophy 9.5
1957 hordeolum 9.5
1958 periostitis 9.5
1959 drug dependence 9.5
1960 bap1 tumor predisposition syndrome 9.5
1961 creatine deficiency disorders 9.5
1962 dysferlinopathy 9.5
1963 etv6 thrombocytopenia and predisposition to leukemia 9.5
1964 trichorhinophalangeal syndrome 9.5
1965 type ii collagen disorders 9.5
1966 was-related disorders 9.5
1967 acquired hemophilia 9.5
1968 allergic encephalomyelitis 9.5
1969 arrhinia 9.5
1970 autoimmune polyglandular syndrome type 3 9.5
1971 autoimmune retinopathy 9.5
1972 beryllium disease 9.5
1973 bronchopulmonary dysplasia 9.5
1974 c1q nephropathy 9.5
1975 candida glabrata 9.5
1976 cataract-glaucoma 9.5
1977 chronic lymphocytic inflammation with pontine perivascular enhancement responsiv 9.5
1978 clostridium septicum infection 9.5
1979 cold urticaria 9.5
1980 coloboma of iris 9.5
1981 congenital contractures 9.5
1982 congenital human immunodeficiency virus 9.5
1983 creeping myiasis 9.5
1984 engraftment syndrome 9.5
1985 eosinophilic pustular folliculitis 9.5
1986 exercise-induced anaphylaxis 9.5
1987 exogenous ochronosis 9.5
1988 fibromatosis 9.5
1989 functioning pancreatic endocrine tumor 9.5
1990 gardner-diamond syndrome 9.5
1991 glioma 9.5
1992 heavy metal poisoning 9.5
1993 hemophilia 9.5
1994 herpes zoster ophthalmicus 9.5
1995 hydroa vacciniforme 9.5
1996 hypoaldosteronism 9.5
1997 ichthyosis follicularis atrichia photophobia syndrome 9.5
1998 ichthyosis, follicular 9.5
1999 interferon gamma, receptor 1, deficiency 9.5
2000 kikuchi disease 9.5
2001 laugier-hunziker syndrome 9.5
2002 ledderhose disease 9.5
2003 leukoplakia 9.5
2004 lichen planus pemphigoides 9.5
2005 lipodermatosclerosis 9.5
2006 lymphomatoid granulomatosis 9.5
2007 marek disease 9.5
2008 mast cell activation syndrome 9.5
2009 meningococcal infection 9.5
2010 microscopic polyangiitis 9.5
2011 morgellons 9.5
2012 mycetoma 9.5
2013 mycobacterium abscessus 9.5
2014 notalgia paresthetica 9.5
2015 paraneoplastic neurologic disorders 9.5
2016 perniosis 9.5
2017 primary localized cutaneous nodular amyloidosis 9.5
2018 quinquaud folliculitis decalvans 9.5
2019 rheumatoid vasculitis 9.5
2020 ring chromosome 2 9.5
2021 secondary adrenal insufficiency 9.5
2022 spitz nevus 9.5
2023 sunct headache 9.5
2024 treponema infection 9.5
2025 undifferentiated connective tissue disease 9.5
2026 weber syndrome 9.5
2027 back pain 9.5
2028 chronic pain 9.5
2029 febrile seizures 9.5
2030 foot drop 9.5
2031 hypotonia 9.5
2032 spinal cord injury 9.5
2033 tremor 9.5
2034 chronic cutaneous lupus erythematosus 9.5
2035 localized pagetoid reticulosis 9.5
2036 interatrial communication 9.5
2037 rare systemic disease 9.5
2038 glial tumor 9.5
2039 chronic beryllium disease 9.5
2040 acute transverse myelitis 9.5
2041 hemimelia 9.5
2042 ichthyosis follicularis-alopecia-photophobia syndrome 9.5
2043 overlapping connective tissue disease 9.5
2044 qualitative or quantitative defects of dysferlin 9.5
2045 rare lymphatic malformation 9.5
2046 autoimmune polyendocrinopathy type 3 9.5
2047 toxic oil syndrome 9.5
2048 acute sensory ataxic neuropathy 9.5
2049 idiopathic nephrotic syndrome 9.5
2050 toxic dermatosis 9.5
2051 hypocalcemic rickets 9.5
2052 familial intrahepatic cholestasis 9.5
2053 disorder of galactose metabolism 9.5
2054 acute radiation syndrome 9.5
2055 cutaneous pseudolymphoma 9.5
2056 chronic enteropathy associated with slco2a1 gene 9.5
2057 eosinophilic colitis 9.5
2058 polyarticular juvenile idiopathic arthritis 9.5
2059 refractory celiac disease 9.5
2060 3q27.3 microdeletion syndrome 9.5
2061 urachal sinus 9.5
2062 neuroendocrine carcinoma of pancreas 9.5
2063 acute monoblastic/monocytic leukemia 9.5
2064 familial keratoacanthoma 9.5
2065 non-histaminic angioedema 9.5
2066 benign idiopathic neonatal seizures 9.5
2067 pneumococcal meningitis 9.5
2068 methotrexate toxicity 9.5
2069 inherited retinal disorder 9.5
2070 classic pyoderma gangrenosum 9.5
2071 striate palmoplantar keratoderma 9.5
2072 autoimmune hemolytic anemia, warm type 9.5
2073 lupus erythematosus panniculitis 9.5
2074 fungal keratitis 9.5
2075 pauci-immune glomerulonephritis 9.5
2076 pemphigus vegetans 9.5
2077 classic phenylketonuria 9.5
2078 erythrokeratoderma 9.5
2079 refractory anemia with excess blasts 9.5
2080 rare tumor 9.5
2081 acute adrenal insufficiency 9.5
2082 refractory anemia 9.5
2083 multiple congenital anomalies/dysmorphic syndrome-intellectual disability 9.5
2084 thyroid carcinoma 9.5
2085 cutaneous myiasis 9.5
2086 idiopathic syringomyelia 9.5

Graphical network of the top 20 diseases related to Dermatitis:



Diseases related to Dermatitis

Symptoms & Phenotypes for Dermatitis

UMLS symptoms related to Dermatitis:


pruritus; exanthema

MGI Mouse Phenotypes related to Dermatitis:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.77 CCL11 CCL17 CCL22 CMA1 IGHE IL13
2 hematopoietic system MP:0005397 9.44 CCL11 CCL17 CMA1 DSG1 IGHE IL13

Drugs & Therapeutics for Dermatitis

PubMed Health treatment related to Dermatitis: 63

Eczema is a chronic condition. Treatment cannot cure it, but regular skin care and medication can help to keep the itching and rash at bay. The main treatment options are: Basic treatment : Lipid -replenishing and moisturizing products (emollients ) are generously applied to the skin at least twice a day to keep it from drying out. This can help relieve itching and protect the skin from germs and irritants. Special soaps, liquid cleansers and shampoos : Normal soaps and products like shampoo or shower gel contain various substances that can dry out your skin . Special cleansing products without these substances are available to get around this problem. But basic treatment with emollients can usually compensate for the loss of moisture caused by normal soaps. Steroid creams : Eczema flare -ups are usually treated with steroid creams because they can relieve the itching and inflammation . They are typically used only for acute symptoms. But they are sometimes used at regular intervals together with moisturizing skin care products (basic treatment ): for example, as a "weekend treatment" where a steroid cream is applied on one or two days a week. Pimecrolimus and tacrolimus : Pimecrolimus and tacrolimus are two other medicines that can be used to treat eczema . They are not approved for use in children under the age of two years, though. These two medicines are also applied to the skin in a cream or ointment, and can be used if steroid products are not an option. This might be the case if steroid treatment is not tolerated or is ineffective. Pimecrolimus and tacrolimus may also be an option for long-term treatment of sensitive skin in the face and neck area. They can also be used on one or two days per week only, as described above. Other eczema treatment options include wet wraps, UV radiation and medications that suppress certain immune responses. Tablets containing these medicines are used if other treatments don't work, or if the eczema is very severe or affects large areas of skin . Because they have an effect throughout the entire body, they may have more extensive side effects than topical treatments. Allergy medications (antihistamines ) are also commonly used to relieve itching . But research has now shown that they are not suitable for treating eczema , whether used as tablets or a cream. People often try out herbal products or dietary supplements, such as evening primrose oil , borage oil, vitamin B6, vitamin E and zinc . But research hasn't shown that these products are effective. Many other treatments such as laser therapies or hyposensitization have not yet been studied enough, so they are not recommended by medical associations.

Drugs for Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 471, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Salicylic acid Approved, Investigational, Vet_approved Phase 4 69-72-7 338
2
Ciclopirox Approved, Investigational Phase 4 29342-05-0 2749
3
Titanium dioxide Approved Phase 4 13463-67-7
4
Glycerin Approved, Investigational Phase 4 56-81-5 753
5
Carbamide peroxide Approved Phase 4 124-43-6
6
Clobetasol Approved, Experimental, Investigational Phase 4 25122-46-7, 25122-41-2 2791 5311051 32798
7
Omalizumab Approved, Investigational Phase 4 242138-07-4
8
Levocetirizine Approved Phase 4 130018-77-8 1549000
9
Triclosan Approved, Investigational Phase 4 3380-34-5 5564
10
Desonide Approved, Investigational Phase 4 638-94-8 5311066
11
Montelukast Approved Phase 4 158966-92-8 5281040
12
Methylprednisolone aceponate Approved, Vet_approved Phase 4 86401-95-8 4474933
13
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
14
Racepinephrine Approved, Vet_approved Phase 4 51-43-4, 329-65-7 838 5816
15
Fluocinonide Approved, Investigational Phase 4 356-12-7 9642
16
Desoximetasone Approved Phase 4 382-67-2 5311067
17
Menthol Approved, Experimental Phase 4 1490-04-6, 2216-51-5, 15356-60-2 1254 16666 165675
18
Brodalumab Approved, Investigational Phase 4 1174395-19-7
19
Mometasone furoate Approved, Investigational, Vet_approved Phase 4 83919-23-7 4240 441336
20
Dicloxacillin Approved, Investigational, Vet_approved Phase 4 3116-76-5 18381
21
Methotrexate Approved Phase 4 1959-05-2, 59-05-2 4112 126941
22
Mycophenolic acid Approved, Investigational Phase 4 24280-93-1 446541
23
Apremilast Approved, Investigational Phase 4 608141-41-9 10151715 11561674
24
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
25
Alitretinoin Approved, Investigational Phase 4 5300-03-8 449171
26
Pimecrolimus Approved, Investigational Phase 4 137071-32-0 17753757 6509979
27
Zinc cation Approved, Experimental, Investigational Phase 4 7440-66-6, 23713-49-7 32051
28
Zinc oxide Approved Phase 4 1314-13-2
29
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
30
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
31
Tannic acid Approved Phase 4 1401-55-4 16129878 16129778
32
Levoleucovorin Approved, Experimental, Investigational Phase 4 68538-85-2, 58-05-9, 73951-54-9 149436 6006
33
Lactitol Approved, Investigational Phase 4 585-86-4 157355
34
Alefacept Approved, Investigational, Withdrawn Phase 4 222535-22-0
35
Dapsone Approved, Investigational Phase 4 80-08-0 2955
36
Cefuroxime Approved Phase 4 55268-75-2 5479529
37
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
38
Halometasone Experimental Phase 4 50629-82-8 12811517
39
Cortisone Experimental Phase 4 53-06-5 222786
40 Cyclooxygenase Inhibitors Phase 4
41
Salicylates Phase 4
42 Acidophilus Phase 4
43 Immunoglobulin E Phase 4
44 Histamine H1 Antagonists, Non-Sedating Phase 4
45 Olive Phase 4
46 Leukotriene Antagonists Phase 4
47 Anti-Arrhythmia Agents Phase 4
48 Sodium Channel Blockers Phase 4
49 Diuretics, Potassium Sparing Phase 4
50 Epinephryl borate Phase 4
51 Evening Primrose Phase 4
52 Linoleate Phase 4
53 Pharmaceutical Solutions Phase 4
54 Immunoglobulin A Phase 4
55 Antitubercular Agents Phase 4
56 Anti-Asthmatic Agents Phase 4
57 Respiratory System Agents Phase 4
58 Analgesics Phase 4
59 Phosphodiesterase Inhibitors Phase 4
60 Phosphodiesterase 4 Inhibitors Phase 4
61 Anti-Inflammatory Agents, Non-Steroidal Phase 4
62 Analgesics, Non-Narcotic Phase 4
63 Hormones Phase 4
64 Betamethasone-17,21-dipropionate Phase 4
65
Betamethasone Valerate Phase 4 2152-44-5
66
Betamethasone sodium phosphate Phase 4
67
Betamethasone benzoate Phase 4
68 Hormone Antagonists Phase 4
69 glucocorticoids Phase 4
70 Immunoglobulins Phase 4
71 Antibodies Phase 4
72 Anti-Infective Agents, Local Phase 4
73 Gentamicins Phase 4
74 Cytochrome P-450 Enzyme Inhibitors Phase 4
75 Cytochrome P-450 CYP3A Inhibitors Phase 4
76 Antibodies, Monoclonal Phase 4
77
Triamcinolone hexacetonide Phase 4
78
Triamcinolone diacetate Phase 4
79
Triamcinolone Acetonide Phase 4 6436
80 Vitamin B Complex Phase 4
81 Folic Acid Antagonists Phase 4
82 Folate Phase 4
83 Vitamin B9 Phase 4
84 Antiprotozoal Agents Phase 4
85 Antiparasitic Agents Phase 4
86 Antimalarials Phase 4
87 Radiation-Protective Agents Phase 4
88 Cathartics Phase 4
89 Laxatives Phase 4
90
Cefuroxime axetil Phase 4 3379942
91 Penicillins Phase 4
92
Histidine Investigational, Nutraceutical Phase 4 71-00-1 6274
93
Cimetidine Approved, Investigational Phase 3 51481-61-9 2756
94
Fexofenadine Approved, Investigational Phase 2, Phase 3 83799-24-0 3348
95
Cetirizine Approved Phase 3 83881-51-0 2678
96
Desloratadine Approved, Investigational Phase 3 100643-71-8 124087
97
Polymyxin B Approved, Vet_approved Phase 3 1405-20-5, 1404-26-8 4868
98
Tolnaftate Approved, Investigational, Vet_approved Phase 3 2398-96-1 5510
99
Lactulose Approved Phase 2, Phase 3 4618-18-2 11333
100
Hyaluronic acid Approved, Vet_approved Phase 3 9004-61-9 53477741
101
Ketotifen Approved Phase 3 34580-14-8, 34580-13-7 3827
102
Bepotastine Approved Phase 3 190786-44-8, 125602-71-3 2350 164522
103
Butenafine Approved Phase 3 101828-21-1 2484
104
Epinastine Approved, Investigational Phase 3 80012-43-7 3241
105
Curcumin Approved, Investigational Phase 2, Phase 3 458-37-7, 84765-67-3 969516
106
Cetuximab Approved Phase 3 205923-56-4
107
Acitretin Approved Phase 2, Phase 3 55079-83-9 5284513
108
Infliximab Approved Phase 3 170277-31-3
109
Tocopherol Approved, Investigational Phase 3 1406-66-2
110
Afamelanotide Approved, Investigational Phase 3 75921-69-6 16132954 16197727
111
Abrocitinib Approved, Investigational Phase 3 1622902-68-4 78323835
112
Cannabidiol Approved, Investigational Phase 3 13956-29-1 521372 644019
113
Ustekinumab Approved, Investigational Phase 2, Phase 3 815610-63-0
114
Adalimumab Approved, Experimental Phase 2, Phase 3 331731-18-1
115
Ketoconazole Approved, Investigational Phase 3 65277-42-1, 142128-57-2 47576 3823 638701
116
BCG vaccine Approved, Investigational Phase 3
117
Fluocinolone acetonide Approved, Investigational, Vet_approved Phase 3 67-73-2 6215
118
Fluticasone Approved, Experimental Phase 3 90566-53-3 4659387 5311101
119
Fusidic acid Approved, Investigational Phase 3 6990-06-3 3000226
120 Coconut Approved Phase 3
121
Crofelemer Approved Phase 3 33507-63-0, 148465-45-6 36511 44359816
122
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3 22737-96-8, 68-26-8 5280382 445354
123
Melatonin Approved, Nutraceutical, Vet_approved Phase 2, Phase 3 73-31-4 896
124
DL-alpha-Tocopherol Approved, Experimental, Investigational, Nutraceutical, Vet_approved Phase 3 59-02-9, 10191-41-0 2116 14985
125
Cholecalciferol Approved, Nutraceutical, Vet_approved Phase 3 67-97-0, 1406-16-2 5280795 10883523
126
Maleic acid Experimental, Investigational Phase 3 110-16-7, 110-17-8 444266 444972